DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
down	IGKV1D-8; IGLV3-21; IGLV7-46; IGLV5-45; IGLV3-19; IGLV9-49; IGLV2-14; IGKV2D-29; IGLV4-69; IGLV2-23; IGKV1-8; IGKV4-1; IGLV6-57; IGLV2-11; IGKV1-27; IGLV1-40; IGLV3-1; IGLV1-44; IGLV3-25; IGLV8-61; IGLV2-18; IGLV7-43; IGLV3-9; IGLV1-47;	GO:0002377~immunoglobulin production	24	107	22.4299065420561	0	0	0	0	0	0	0
down	KLK10; KLK8; LTF; ELANE; MMP3; CTSG; AZU1; GZMH; ENDOU; MMP8; PRSS3; GGT5; KLK7; ADAM15; PRSS8; PRSS36; GGT6; TMPRSS11F; ASRGL1; PRSS33; ADAMTS14; GGH; SCRN2; CAPNS2; PRSS27; TMPRSS13; PRSS22; CHMP1A; TMPRSS4; KLK11; KLK12; TMPRSS11E; KLK5; CAPN14; THOP1; CPA4;	GO:0006508~proteolysis	36	436	8.25688073394496	0	0	0	0	0	0	0
down	IGHV4-39; IGHV3-74; IGLL5; IGHG2; IGHV3-30; IGHV1-2; IGHV4-4; TRDC; IGHV1-46; IGHA2; IGHA1; IGHV1-3; IGHG4; IGHV3-15; IGHV3-49; IGHV1-69-2; IGHV3-20; IGHV3-21; IGLC3; IGHE; IGHV2-70; IGHV3-53; IGHG3; IGHV3-7; IGHV2-5; IGHD; IGHV2-26; IGHV5-51; IGHV3-73; IGKC; IGHV6-1; IGHV3-48; IGHV1-24; IGHV4-59; IGHV4-34; IGHV3-33;	GO:0006910~phagocytosis, recognition	36	99	36.3636363636364	0	0	0	0	0	0	0
down	NCR3; LY86; ORM1; ANXA1; KRT16; FOLR2; ALOX15; AZU1; BDKRB2; ADORA1; FCGR2B; CARD18; ELF3; FUT7; IL18; ECM1; AOC3; NLRP10; PLD4; MGLL; TOLLIP; PROK2; PF4; PTGDR; IL36A; ACKR1; PF4V1; CCL26; IL36G; IL36RN; XCL1; IL1RN; GGT5;	GO:0006954~inflammatory response	33	381	8.66141732283465	0	0	0	0	0	0	0
down	NCR3; CXCL14; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV3-19; IGLV3-1; IGLV3-25; IGLV6-57; CD8A; IGHV1-46; IGHV3-48; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHE; IGHA1; IGHA2; IGHD; SLPI; IGLV7-43; CD1A; IGKV4-1; IGHV4-34; CTSG; CD8B; GZMA; IL1RN; ENDOU; IGHV1-2; HRH2; FCGR2B; CD79B; CTSW; DEFB1; IGLV3-21; GBP6; IL36A; IGKV1D-8; IGLV8-61; IGLV5-45; CXCR1; IGLV9-49; IGKV2D-29; IGKV1-27; IGLV7-46; CD1C; PF4V1; IGLV4-69; IGLV3-9; IGLV2-18; RAET1L; PF4; IGKV1-8; RAET1E;	GO:0006955~immune response	64	433	14.7806004618938	0	0	0	0	0	0	0
down	FCN1; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV3-19; IGLV3-1; IGLV3-25; IGLV6-57; IGHV1-46; IGHV3-48; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHG2; IGHG3; IGHG4; C1QA; IGLV7-43; IGKV4-1; IGHV4-34; IGLC3; IGHV1-2; IGLV3-21;	GO:0006956~complement activation	32	92	34.7826086956522	0	0	0	0	0	0	0
down	IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV3-19; IGLV3-1; IGLV3-25; IGLV6-57; IGHV1-46; IGHV3-48; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHG2; IGHG3; IGHG4; C1QA; IGLV7-43; IGKV4-1; IGHV4-34; IGLC3; IGHV1-2; IGLV3-21; TRDC; IGHV4-4; IGHV3-21; IGHV5-51; IGHV3-20; IGHD; IGHV1-24; IGHV1-69-2; IGHV3-49; IGLL5; IGHV2-26; IGHV3-15; IGHV6-1; IGHV3-74; IGHE; IGHV1-3; IGHA2; IGHA1; IGHV3-73;	GO:0006958~complement activation, classical pathway	50	161	31.055900621118	0	0	0	0	0	0	0
down	IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV3-19; IGLV3-1; IGLV3-25; IGLV6-57; IGHV1-46; IGHV3-48; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHG2; IGHG3; IGHG4; C1QA; IGLV7-43; IGKV4-1; IGHV4-34; IGLC3; CD19; IGHV1-2; IGLV3-21; CR1L;	GO:0030449~regulation of complement activation	33	113	29.2035398230088	0	0	0	0	0	0	0
down	KRT86; KRT14; KRT6A; KRT6B; KRT1; KRT18; KRT7; KRT16; KRT10; KRT13; KRT5; JUP; DSP; KRT15; KRT4; SFN; DSG3; KRT9; KRT2; KRT6C; DSG1; DSC2; KRT17; PKP1; DSC3; KRT80; HRNR; KRT78; CNFN; KRT23; PKP3;	GO:0031424~keratinization	31	181	17.1270718232044	0	0	0	0	0	0	0
down	ELANE; ANXA3; DEFB1; ROMO1; LCN2; CEBPE; GBP6; WFDC12; S100A14; SLAMF8; IGHV3-48; IGHV6-1; GSDMA; IGHG2; IGLC3; IGHG3; IGHV1-46; IGHV3-53; IGHV1-24; IGHV3-73; IGHV1-2; IGHA1; IGHV3-30; IGHA2; IGLL5; IGHV2-5; IGHD; IGHV3-49; IGHV3-74; IGHV2-70; IGHV3-7; GSDMC; IGHE; IGHV4-34; IGHV3-15; IGHV5-51; IGHV1-69-2; TRDC; IGHV3-20; IGKC; IGHV4-39; IGHV2-26; IGHV4-4; IGHV3-21; IGHV4-59; IGHV1-3; IGHV3-33; IGHG4;	GO:0042742~defense response to bacterium	48	216	22.2222222222222	0	0	0	0	0	0	0
down	FCN1; AGPAT2; SYNGR1; CREG1; ORM1; LTF; SLPI; CSTB; KRT1; ELANE; CTSG; ACAA1; GSTP1; ALDOC; RNASE2; MGST1; PYGB; ANXA3; RNASE3; DEFA4; JUP; DSP; BPI; GM2A; PSMC3; AOC1; AZU1; MMP8; CXCR1; S100P; PRSS3; CEACAM3; CEACAM6; MNDA; HK3; CRISP3; VAMP2; DYNLL1; CSNK2B; TUBB4B; LCN2; FABP5; DSG1; PLD1; PKP1; HRNR; GGH; MS4A3; SERPINB12; ADGRE3; TOLLIP; RETN; CD300A;	GO:0043312~neutrophil degranulation	53	483	10.9730848861284	0	0	0	0	0	0	0
down	LILRA5; LY86; C1QA; SLPI; ANXA1; S100B; KRT16; SAA1; RNASE3; DEFA4; IFI27; KIR2DS4; CRISP3; DEFB1; LCN2; MST1R; KLRD1; ADAM15; SERINC3; TRIM29; NLRX1; NLRP10; CLEC10A; ZNF683; LILRA2; RNASE6; PLD4; PGLYRP4; PGLYRP3; SIGLEC10; WRNIP1; SPON2; PLA2G2F; TOLLIP; RNASE7; IL36G; IL36RN; TRIM10; IL36A; TRDC; IGHV3-15; IGHA1; IGHV3-48; IGHV2-70; IGHV1-69-2; IGHV2-26; IGHV4-59; IGHV4-39; IGHV3-53; IGHV1-3; IGHV4-4; IGHV3-30; IGLC3; IGHV3-49; IGHV1-2; IGHV3-21; IGHV6-1; IGHV5-51; IGHV3-7; IGHV3-33; IGHV1-46; IGHG4; IGHA2; IGLL5; IGHV3-74; IGHV1-24; IGHV3-73; IGHG3; BPI; IGHV4-34; IGKC; IGHV2-5; IGHE; IGHD; IGHG2; IGHV3-20;	GO:0045087~innate immune response	76	505	15.049504950495	0	0	0	0	0	0	0
down	NCR3; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV3-19; IGLV3-1; IGLV3-25; IGLV6-57; CD8A; IGHV1-46; IGHV3-48; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGLV7-43; CD1A; IGKV4-1; IGHV4-34; IGLC3; CD8B; CD19; IGHV1-2; CD1C; FCGR2B; ICAM3; CXADR; IGLV3-21; KLRD1; RAET1E; CD300A; SIGLEC7; BTNL8; BTNL3;	GO:0050776~regulation of immune response	42	216	19.4444444444444	0	0	0	0	0	0	0
down	IGHV2-26; IGHV3-53; IGHG3; IGHV3-49; IGHV1-69-2; IGHG4; IGLC3; IGHV3-15; IGHV4-39; IGHV2-70; IGHV3-21; IGHD; IGHV4-59; IGHV4-4; IGHV3-73; IGHV1-2; IGLL5; IGHV1-24; IGHA1; IGHV3-74; IGHV3-48; IGHG2; IGHV3-33; IGHE; IGHV3-20; IGHV1-46; IGHV5-51; IGHV1-3; IGHV6-1; IGHV4-34; IGHV3-7; IGHA2; TRDC; IGKC; IGHV3-30; IGHV2-5;	GO:0050871~positive regulation of B cell activation	36	98	36.734693877551	0	0	0	0	0	0	0
down	PIR; SCD; HR; AKR1B10; ALOX12B; BBOX1; TM7SF2; CYP2E1; TXN; MGST1; CYP4B1; AOC1; FDXR; ALDH3A1; ADH7; ALDH1A3; ALDH3B2; AKR1C2; PRDX1; DHCR24; NSDHL; AOC3; HEPHL1; CYP4F22; FA2H; SCD5; FOXRED2; SDR16C5; FADS6; SDR9C7; DHRS1; HSD3B7; JMJD4; CYP4F12; DUOX2; DUOX1; CYB5R1; HIGD1A; PTGES;	GO:0055114~oxidation-reduction process	39	526	7.41444866920152	0	0	0	0	0	0	0
down	PPL; SCEL; CCNB1; IGFBP2; KCNA5; ENDOG; RETN;	GO:0009612~response to mechanical stimulus	7	57	12.280701754386	0.00011053045069164	0.00355413371544077	0.323080507371688	0.333249308835319	0.251677836224883	0.323080507371688	0.0305255183315402
down	CLDN7; CLDN1; CYP2E1; GSTP1; MAOB; ADH7; EIF4EBP1; GGH; PEMT;	GO:0045471~response to ethanol	9	100	9	0.00011080881235536	0.00355413371544077	0.323783349702384	0.334088569251433	0.251981210784006	0.323783349702384	0.0305255183315402
down	AOC1; GJB2; ID1; ENDOG; AOC3;	GO:0046677~response to antibiotic	5	24	20.8333333333333	0.00012144791167134	0.00381422347592822	0.354749349992002	0.366165453689109	0.265078965727221	0.354627902080331	0.0327593607773416
down	BDKRB2; PLA2G4F; PLA2G2F; PLA2G3; ANXA1;	GO:0050482~arachidonic acid secretion	5	24	20.8333333333333	0.00012144791167134	0.00381422347592822	0.354749349992002	0.366165453689109	0.265078965727221	0.354627902080331	0.0327593607773416
down	TM7SF2; MVD; IDI1; PMVK; DHCR24; NSDHL;	GO:0006695~cholesterol biosynthetic process	6	40	15	0.00012778295070536	0.0039718102719246	0.372998433108971	0.385265596376686	0.272177685002435	0.372998433108971	0.0341128322601667
down	RAMP2; ASS1; CRYAB; GSTP1; IGFBP2; GJB2; ENDOG; ANXA1; GGT5;	GO:0032355~response to estradiol	9	103	8.7378640776699	0.00013648105447006	0.00419888142068607	0.398251716943639	0.411490379227235	0.281969858535146	0.398251716943639	0.0360630865468776
up	DVL1; NRP1; FLRT2; SLIT1; SLIT3; GLI3; SPTB; ANOS1; PAX6; SHC1; L1CAM; GPC1; WNT5A; LAMB2; WNT3; SEMA3F; TUBB3; CRMP1; EXT1; FOXD1; ARTN; FEZ1; SEMA3C; SHANK3; OR10A4; FLRT3; MYOT; ROBO1; BSG; LAMA1; EFNB2; EFNB1; EFNB3; PALLD;	GO:0007411~axon guidance	34	206	16.504854368932	0.00014307036578764	0.0576430503758423	0.575142870466334	0.576430503758423	0.573998307540033	0.575142870466334	0.511790350562543
down	ADORA1; PLCD1; PLD1; LIPK; LIPH; PLA2G2F; PLA2G3; PNLIPRP3;	GO:0016042~lipid catabolic process	8	81	9.87654320987654	0.00014673911063478	0.00446887291478666	0.428037985721671	0.44241841856388	0.293478221269572	0.428037985721671	0.0383819723745892
down	MT-CO2; DUOXA1; DUOXA2;	GO:0010729~positive regulation of hydrogen peroxide biosynthetic process	3	4	75	0.00016505012740641	0.00492699142703319	0.481286171517117	0.497626134130352	0.312439415343369	0.48112112138971	0.0423166316089464
down	TJP1; ANGPT1; OCLN;	GO:1905605~positive regulation of maintenance of permeability of blood-brain barrier	3	4	75	0.00016505012740641	0.00492699142703319	0.481286171517117	0.497626134130352	0.312439415343369	0.48112112138971	0.0423166316089464
down	PLA2G4E; PLA2G4F; PLA2G4D; PLA2G2F; PLA2G3;	GO:0036152~phosphatidylethanolamine acyl-chain remodeling	5	26	19.2307692307692	0.00016892577356397	0.00499324713034697	0.492249704165429	0.509311207295391	0.316397973885329	0.492249704165429	0.0428856843931135
down	RHOD; GIPC1; SYNGR1; NLGN1; AP1S3; HAP1;	GO:0006605~protein targeting	6	43	13.953488372093	0.00018266327116489	0.00524504535773486	0.532098108903341	0.55072976256216	0.330437857537296	0.531732782361011	0.045048313045093
down	CLDN5; DSG1; TJP1; PKP3; PKP1; CDH26;	GO:0007043~cell-cell junction assembly	6	43	13.953488372093	0.00018266327116489	0.00524504535773486	0.532098108903341	0.55072976256216	0.330437857537296	0.531732782361011	0.045048313045093
down	MMP3; MMP8; ADAM15; COL13A1; ADAMTS14; KLK6;	GO:0030574~collagen catabolic process	6	43	13.953488372093	0.00018266327116489	0.00524504535773486	0.532098108903341	0.55072976256216	0.330437857537296	0.531732782361011	0.045048313045093
down	ALOX15B; ALOX12B; ALOX15; MGLL; CYP4F12;	GO:0019369~arachidonic acid metabolic process	5	27	18.5185185185185	0.00019740323441641	0.00551084029412494	0.574246008917353	0.595170751765493	0.342114788621123	0.574048605682937	0.0473311557439923
down	RAMP2; ANXA1; HSPB1; MT1G; GAS1;	GO:0035924~cellular response to vascular endothelial growth factor stimulus	5	27	18.5185185185185	0.00019740323441641	0.00551084029412494	0.574246008917353	0.595170751765493	0.342114788621123	0.574048605682937	0.0473311557439923
down	LILRA5; ALOX12B; ADRB2; IGFBP3; FGFR3; MMP8; NTRK2; WWC1; ROR2;	GO:0043410~positive regulation of MAPK cascade	9	109	8.25688073394496	0.00020286016174231	0.00561122373993646	0.589714490184904	0.611623387653074	0.345673715608902	0.589714490184904	0.0481933227193062
down	VGLL3; FOXN1; CREG1; EGFR; TGFA; TAL1; USF1; ECM1; NFE4; OLIG1; ARNTL2; VGLL1; POU2F3; RUVBL2; BATF; NR2F6; MED18; FOXC1; GRHL3; KLF5; GRHL1; HOPX; MED31; DLX3; FOXQ1; EHF; ELF3; BARX2;	GO:0006357~regulation of transcription by RNA polymerase II	28	747	3.7483266398929	0.0002109075985528	0.00578078554215177	0.612897481394439	0.635886409636695	0.350923291338802	0.612897481394439	0.0496496443763575
down	RHOD; MYO1B; AIF1L; RND3; PLS3; ESPNL;	GO:0051017~actin filament bundle assembly	6	45	13.3333333333333	0.00022854234416636	0.00617524617920519	0.663915509803277	0.689055167661576	0.36228714525609	0.663915509803277	0.0530375628880142
down	CTSG; DEFA4; NLRP10; SPON2; RNASE7;	GO:0050832~defense response to fungus	5	28	17.8571428571429	0.00022939554629219	0.00617524617920519	0.666164666432547	0.691627572070981	0.362903754234259	0.666164666432547	0.0530375628880142
up	NRP1; SEMA3F; PLXNA2; PLXNB2; PLXNB1; PLXNA1; PLXNB3;	GO:1902287~semaphorin-plexin signaling pathway involved in axon guidance	7	12	58.3333333333333	0.00024230415689441	0.0837376952482561	0.973820406558645	0.976243448127589	0.798634501123985	0.973820406558645	0.743474610156388
down	MUC1; PSMC3; PSMB6; ICAM3; CLEC10A; MUC15; MUC16; MUCL1; MUC4;	GO:0002223~stimulatory C-type lectin receptor signaling pathway	9	112	8.03571428571429	0.00024498168823727	0.00653645831889728	0.711181840952818	0.738619790035393	0.372944691945288	0.711181840952818	0.0561399188134098
up	NRP1; LAMA5; SEMA7A; ITGAV; ITGA2B; ITGA2; ITGB5; ITGA3; CD40LG; MYH9; BCAR1; COL16A1; DOCK1; FERMT3; FERMT2; FERMT1; ADAMTS1; ITGB6; ITGB4; LAMA3;	GO:0007229~integrin-mediated signaling pathway	20	96	20.8333333333333	0.00024940490021818	0.0837376952482561	1	1	0.808625101409105	0.999999845920836	0.743474610156388
down	LTF; DEFA4; IL36RN;	GO:0019732~antifungal humoral response	3	5	60	0.00026071935593241	0.00670761626159641	0.756346851559936	0.786068858136231	0.381879501921798	0.755825412848071	0.0576099493006569
down	EGFR; DUOXA1; DUOXA2;	GO:0042743~hydrogen peroxide metabolic process	3	5	60	0.00026071935593241	0.00670761626159641	0.756346851559936	0.786068858136231	0.381879501921798	0.755825412848071	0.0576099493006569
down	KRT10; KRT2; TMEM79;	GO:0045684~positive regulation of epidermis development	3	5	60	0.00026071935593241	0.00670761626159641	0.756346851559936	0.786068858136231	0.381879501921798	0.755825412848071	0.0576099493006569
down	SLC9A3R1; EGFR; PTPN3; GAS1; FOXC1;	GO:0045930~negative regulation of mitotic cell cycle	5	29	17.2413793103448	0.0002651816040311	0.00670761626159641	0.768496288482146	0.799522536153785	0.384248144241073	0.768496288482146	0.0576099493006569
down	SCD; SCD5; ELOVL1; ELOVL4;	GO:0006636~unsaturated fatty acid biosynthetic process	4	15	26.6666666666667	0.00026696980145657	0.00670761626159641	0.773411514819694	0.804913951391569	0.385237423501836	0.773144545018237	0.0576099493006569
down	GGT5; GGT6; MGST2; CHAC1;	GO:0006750~glutathione biosynthetic process	4	15	26.6666666666667	0.00026696980145657	0.00670761626159641	0.773411514819694	0.804913951391569	0.385237423501836	0.773144545018237	0.0576099493006569
down	RAB11A; CHMP1B; CHMP4C; VPS25; CHMP1A;	GO:0036258~multivesicular body assembly	5	30	16.6666666666667	0.00030504953436971	0.00760102765392311	0.88311840200033	0.919724346124696	0.405715880711723	0.88311840200033	0.0652832244269118
down	ATP6V0E1; ATP2C2; MT-CO2; COX8A; COX7A2; SLC15A1; OTOP3; ATP6V1C2; ATP12A;	GO:1902600~proton transmembrane transport	9	116	7.75862068965517	0.00031218946923872	0.00771517417831759	0.903476323976861	0.941251249754746	0.409592583641203	0.903476323976861	0.0662635988590125
down	ALOX15B; ALOX12B; ALOX15; PLA2G3;	GO:0019372~lipoxygenase pathway	4	16	25	0.00032920990412876	0.00806965740608324	0.952404252644528	0.992567860948238	0.418754520476957	0.952404252644528	0.0693081619322513
up	MYO1C; SNAI2; ACTN4; PLAU; PDGFB; PDGFA; ITGAV; LAMB1; IGF1R; F3; MDK; CORO1A; MCAM; NOTCH1; CD151; MMP14; CDH13; BCAR1; CCL7; CAV1; LAMC2; TRIP6; PLET1; FAM83H; FERMT3; PDPN; TWIST2; SMO; ZNF703; SPHK1; PDGFC; SEMA6D; SEMA3F; SEMA3C; SEMA7A;	GO:0030335~positive regulation of cell migration	35	226	15.4867256637168	0.00033630213087065	0.0938695803169277	1	1	0.908688357612518	0.999999845920836	0.833431699126267
down	CA2; ASS1; KRT14; PLN; GGH;	GO:0010043~response to zinc ion	5	31	16.1290322580645	0.0003492963570475	0.00835816282935093	1	1	0.428237333740237	0.99546503601856	0.0717860590210541
down	EGFR; ASS1; GJB2; AQP1; EIF4EBP1;	GO:0071549~cellular response to dexamethasone stimulus	5	31	16.1290322580645	0.0003492963570475	0.00835816282935093	1	1	0.428237333740237	0.99546503601856	0.0717860590210541
down	PRMT5; CLDN1; EGFR; PTPN3; CSNK2B;	GO:0097421~liver regeneration	5	31	16.1290322580645	0.0003492963570475	0.00835816282935093	1	1	0.428237333740237	0.99546503601856	0.0717860590210541
up	WNT5A; PTK7; FZD2; SFRP1; CELSR1; VANGL2; DVL1;	GO:0090179~planar cell polarity pathway involved in neural tube closure	7	13	53.8461538461538	0.00034947721636979	0.0938695803169277	1	1	0.916541990312514	0.999999845920836	0.833431699126267
down	CXCR1; FOXC1; ACKR1; CCL26; XCL1; PF4V1; PF4;	GO:0070098~chemokine-mediated signaling pathway	7	70	10	0.00035335240579925	0.00838864175972251	1	1	0.430048119651845	0.99546503601856	0.0720478345259377
down	EGFR; TGFA; BTC; GRB7; FAM83B; EPGN;	GO:0007173~epidermal growth factor receptor signaling pathway	6	50	12	0.00038332403538321	0.00862303875364408	1	1	0.443026037005612	0.99546503601856	0.0740610085671186
down	DSP; GRHL1; PERP;	GO:0002934~desmosome organization	3	6	50	0.00038610621284973	0.00862303875364408	1	1	0.444022144777195	0.99546503601856	0.0740610085671186
down	ALOX15B; ALOX12B; ALOX15;	GO:0034440~lipid oxidation	3	6	50	0.00038610621284973	0.00862303875364408	1	1	0.444022144777195	0.99546503601856	0.0740610085671186
down	ALOX15B; ALOX12B; ALOX15;	GO:0051122~hepoxilin biosynthetic process	3	6	50	0.00038610621284973	0.00862303875364408	1	1	0.444022144777195	0.99546503601856	0.0740610085671186
down	CLDN4; SLC9A3R1; KCNQ1;	GO:0070293~renal absorption	3	6	50	0.00038610621284973	0.00862303875364408	1	1	0.444022144777195	0.99546503601856	0.0740610085671186
down	JUP; DSP; DSC2;	GO:0086073~bundle of His cell-Purkinje myocyte adhesion involved in cell communication	3	6	50	0.00038610621284973	0.00862303875364408	1	1	0.444022144777195	0.99546503601856	0.0740610085671186
down	DSP; TJP1; CGNL1;	GO:0150105~protein localization to cell-cell junction	3	6	50	0.00038610621284973	0.00862303875364408	1	1	0.444022144777195	0.99546503601856	0.0740610085671186
down	GJB6; GJB2; GJB4;	GO:1990349~gap junction-mediated intercellular transport	3	6	50	0.00038610621284973	0.00862303875364408	1	1	0.444022144777195	0.99546503601856	0.0740610085671186
down	KRT1; ID1; EMP2; GPNMB; PROK2;	GO:0045765~regulation of angiogenesis	5	32	15.625	0.00039822763266883	0.00882835523894513	1	1	0.448028913407876	0.99546503601856	0.0758244177794946
up	TBX3; IFNG; CCND1; SOX9; CAV1; SMO;	GO:0030857~negative regulation of epithelial cell differentiation	6	9	66.6666666666667	0.00040877725537247	0.102935222618481	1	1	0.948851244823171	0.999999845920836	0.913922030941372
down	HSPB1; GSTP1; SFN; TARBP2; CAMK2N1; TESC; TRIB3;	GO:0006469~negative regulation of protein kinase activity	7	72	9.72222222222222	0.00041359854548006	0.00903622909146664	1	1	0.453126933348407	0.99546503601856	0.0776097915453227
down	CREG1; FLG; TCL1A; ELF3; TLE1; CLC; SHISA2; SLC22A16; EHF; TBX21; RARG; ROR2; FGFR3; EGFR; ERBB3; MST1R; NTRK2; SPINK6; CDH26; EPHB3; SPINK5;	GO:0007275~multicellular organism development	21	513	4.09356725146199	0.00042474063384712	0.00921289936006524	1	1	0.45675279779809	0.99546503601856	0.0791271659477869
down	CXCL14; RNASE2; DEFB1; PLD1; CMTM2; CMTM5; PROK2; CCL26; CXCR1;	GO:0006935~chemotaxis	9	122	7.37704918032787	0.0004410063719259	0.00949738722397564	1	1	0.46216742204295	0.99546503601856	0.0815705572774856
up	PLXNB2; PLXNB1; ATP10A; F2; FN1; TPM1; CCL2; CORO1A; MYH9; CCL7; FGD1; DMTN; RHOU; PDPN; BVES; FBLIM1; LPAR1; FERMT2; DLC1; MYO10; PARVA; WASF3; PLXNB3; PLXNA1; RAC3; RHOB; PLXNA2;	GO:0008360~regulation of cell shape	27	159	16.9811320754717	0.00044427128293012	0.105292294054438	1	1	0.966793539516575	0.999999845920836	0.934849556612625
down	NTRK2; EPHB3; ROR2; EGFR; ERBB3; MST1R; FGFR3;	GO:0033674~positive regulation of kinase activity	7	73	9.58904109589041	0.00044665157522716	0.00953955491439959	1	1	0.463998407095009	0.99546503601856	0.0819327244636673
down	ALDH3B2; FA2H; CERS3; SPTSSB; ELOVL1; ELOVL4;	GO:0030148~sphingolipid biosynthetic process	6	52	11.5384615384615	0.00046426507129482	0.00978852580387336	1	1	0.469414717877231	0.99546503601856	0.0840710698550165
down	PLA2G4F; PLA2G4D; PLA2G2F; PLA2G3;	GO:0036148~phosphatidylglycerol acyl-chain remodeling	4	18	22.2222222222222	0.00048373275516377	0.00985442065418105	1	1	0.475020658748549	0.99546503601856	0.0846370233677621
down	TUBB4B; PRDX1; IL18; RAET1E;	GO:0042267~natural killer cell mediated cytotoxicity	4	18	22.2222222222222	0.00048373275516377	0.00985442065418105	1	1	0.475020658748549	0.99546503601856	0.0846370233677621
down	DSP; KRT9; KRT2; KRT17;	GO:0045109~intermediate filament organization	4	18	22.2222222222222	0.00048373275516377	0.00985442065418105	1	1	0.475020658748549	0.99546503601856	0.0846370233677621
down	ALOX15B; MT1G; MT1X; PTK6;	GO:0045926~negative regulation of growth	4	18	22.2222222222222	0.00048373275516377	0.00985442065418105	1	1	0.475020658748549	0.99546503601856	0.0846370233677621
down	TSPAN15; DUOXA2; TESC; STUB1;	GO:0051604~protein maturation	4	18	22.2222222222222	0.00048373275516377	0.00985442065418105	1	1	0.475020658748549	0.99546503601856	0.0846370233677621
down	SPINT2; MAP7; RHOD; RND3; PARVG; RHOV;	GO:0007163~establishment or maintenance of cell polarity	6	53	11.3207547169811	0.00050942556987032	0.0102792666204047	1	1	0.482200197057429	0.99546503601856	0.0882859134682383
down	SCD; TM7SF2; MVD; IDI1; PMVK;	GO:0045540~regulation of cholesterol biosynthetic process	5	34	14.7058823529412	0.00051140629952262	0.0102792666204047	1	1	0.482767546749354	0.99546503601856	0.0882859134682383
down	GATA1; TAL1; CDKN2B;	GO:0030219~megakaryocyte differentiation	3	7	42.8571428571429	0.00054457267825303	0.0107312851302803	1	1	0.492126889896074	0.99546503601856	0.0921681813889579
down	RNASE2; RNASE3; SPON2;	GO:0043152~induction of bacterial agglutination	3	7	42.8571428571429	0.00054457267825303	0.0107312851302803	1	1	0.492126889896074	0.99546503601856	0.0921681813889579
down	NUPR1; MMP8; IL18;	GO:0150078~positive regulation of neuroinflammatory response	3	7	42.8571428571429	0.00054457267825303	0.0107312851302803	1	1	0.492126889896074	0.99546503601856	0.0921681813889579
down	SAA1; XCL1; CXADR; CXCR1; PF4; CCL26; PF4V1;	GO:0030593~neutrophil chemotaxis	7	76	9.21052631578947	0.00055862233716708	0.0109366645880438	1	1	0.496056635404368	0.99546503601856	0.0939321314552273
down	LTF; DEFA4; ROMO1; PGLYRP4; PGLYRP3;	GO:0031640~killing of cells of other organism	5	35	14.2857142857143	0.00057630419482857	0.0109542149359684	1	1	0.501003749771164	0.99546503601856	0.0940828667708315
down	SLC9A3R1; NUPR1; BCAP31; SIAH1; BOK;	GO:2001244~positive regulation of intrinsic apoptotic signaling pathway	5	35	14.2857142857143	0.00057630419482857	0.0109542149359684	1	1	0.501003749771164	0.99546503601856	0.0940828667708315
down	LTF; RNASE3; DEFB1; DEFA4;	GO:0002227~innate immune response in mucosa	4	19	21.0526315789474	0.00057768496677246	0.0109542149359684	1	1	0.501430551158498	0.99546503601856	0.0940828667708315
down	CHMP1B; FBXW5; CHMP4C; CHMP1A;	GO:0010824~regulation of centrosome duplication	4	19	21.0526315789474	0.00057768496677246	0.0109542149359684	1	1	0.501430551158498	0.99546503601856	0.0940828667708315
down	PLA2G4E; PLA2G4F; PLA2G4D; PLA2G2F;	GO:0036149~phosphatidylinositol acyl-chain remodeling	4	19	21.0526315789474	0.00057768496677246	0.0109542149359684	1	1	0.501430551158498	0.99546503601856	0.0940828667708315
down	CFL1; EPS8L1; ADGRG1; RHOD; CDC42EP1; RHOV; RND3;	GO:0007266~Rho protein signal transduction	7	77	9.09090909090909	0.00060053293144668	0.0113162924269485	1	1	0.507914146319732	0.99546503601856	0.0971926549705081
down	RAMP1; RAMP2; PF4; ADGRF1; ADGRG6; ADGRE3; PTGDR; ADGRG1;	GO:0007189~adenylate cyclase-activating G protein-coupled receptor signaling pathway	8	103	7.76699029126214	0.00066099133737396	0.0123781918147981	1	1	0.522103566403969	0.99546503601856	0.106313029110972
down	OVOL1; DKK1; ELANE; NR2F6; TXN; RARG; GATA1; TAL1; IFI27; HHEX; ZBTB16; FOXC1; KLF5; TRIM29; MLIP; NRARP; WWC1; SDR16C5; TRIB3; FOXQ1; SIRT7; MAD2L2; TBX21; NOTCH3; BARX2; ID1; HES6; HES2; CC2D1A;	GO:0000122~negative regulation of transcription by RNA polymerase II	29	847	3.42384887839433	0.00066912747048286	0.0124532057006533	1	1	0.523810096827043	0.99546503601856	0.106957303618103
up	PRSS23; FSTL3; F2; SERPINA1; CALCA; APOA2; FN1; APP; LAMB1; MMP2; MELTF; LGALS1; UBB; LAMC1; CDH2; TNC; SNCA; LAMB2; HSPG2; CKAP4; MFGE8; FSTL1; GAS6; TMEM132A; TSPAN33; FAM20C; PCSK9; SCG3; EVA1A; NAT8; ZDHHC2;	GO:0044267~cellular protein metabolic process	31	200	15.5	0.00070009822142469	0.134318844481909	1	1	0.999999845920836	0.999999845920836	1
down	BANF1; HSPB1; CFL1; XCL1; LCN2; MST1R; DUOX2; TBX21;	GO:0009615~response to virus	8	104	7.69230769230769	0.00070133828223084	0.0129441759164762	1	1	0.530531737064865	0.99546503601856	0.111174117481416
down	MAOB; DUOX2; DUOX1;	GO:0050665~hydrogen peroxide biosynthetic process	3	8	37.5	0.00073928262934996	0.0131889770857406	1	1	0.53808966908404	0.99546503601856	0.113276650244181
down	AQP1; SCNN1A; SCNN1B;	GO:0050891~multicellular organismal water homeostasis	3	8	37.5	0.00073928262934996	0.0131889770857406	1	1	0.53808966908404	0.99546503601856	0.113276650244181
down	LTF; RNASE7; DEFA4;	GO:0051673~membrane disruption in other organism	3	8	37.5	0.00073928262934996	0.0131889770857406	1	1	0.53808966908404	0.99546503601856	0.113276650244181
down	GLTP; CPTP; PLEKHA3;	GO:0120009~intermembrane lipid transfer	3	8	37.5	0.00073928262934996	0.0131889770857406	1	1	0.53808966908404	0.99546503601856	0.113276650244181
down	CPTP; PLEKHA3; GLTP;	GO:1902389~ceramide 1-phosphate transport	3	8	37.5	0.00073928262934996	0.0131889770857406	1	1	0.53808966908404	0.99546503601856	0.113276650244181
down	CLDN5; CLDN4; CLDN7; CLDN1;	GO:0016338~calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules	4	21	19.047619047619	0.00080320492829155	0.0140794352255758	1	1	0.549589597399454	0.99546503601856	0.120924560662667
down	PLA2G4E; PLA2G4F; PLA2G4D; PLA2G2F;	GO:0036150~phosphatidylserine acyl-chain remodeling	4	21	19.047619047619	0.00080320492829155	0.0140794352255758	1	1	0.549589597399454	0.99546503601856	0.120924560662667
down	CLDN1; CXADR; TJP1; OCLN;	GO:0045216~cell-cell junction organization	4	21	19.047619047619	0.00080320492829155	0.0140794352255758	1	1	0.549589597399454	0.99546503601856	0.120924560662667
down	JUP; DSP; KCNA5; KCNQ1; DSC2;	GO:0086091~regulation of heart rate by cardiac conduction	5	38	13.1578947368421	0.00080828275582556	0.014086546293723	1	1	0.550465731472973	0.99546503601856	0.120985635753944
up	PLXNA2; SOX9; WNT3; SOX4; SEMA3C; ZNF219;	GO:0060174~limb bud formation	6	11	54.5454545454545	0.00089080199317837	0.163138237750711	1	1	0.999999845920836	0.999999845920836	1
down	LILRA5; TAL1; ERBB3; CD24; DOK7;	GO:0061098~positive regulation of protein tyrosine kinase activity	5	39	12.8205128205128	0.00089919969427043	0.015580960219686	1	1	0.563798208307563	0.99546503601856	0.133820763338962
down	EGFR; ELANE; CD24; MST1R; TPD52L1; EPGN;	GO:0043406~positive regulation of MAP kinase activity	6	60	10	0.00092877927181223	0.0157736914809517	1	1	0.568249504050012	0.99546503601856	0.135476081377016
down	CTSV; S100B; ANXA3; IGFBP2; IL1RN; ALDH3A1;	GO:0051384~response to glucocorticoid	6	60	10	0.00092877927181223	0.0157736914809517	1	1	0.568249504050012	0.99546503601856	0.135476081377016
down	FCER2; KCNA5; PLN; FOXC1; NRARP; PERP; CHAC1; NOTCH3;	GO:0007219~Notch signaling pathway	8	109	7.3394495412844	0.00093386079008017	0.0157736914809517	1	1	0.56882857621311	0.99546503601856	0.135476081377016
down	LILRA5; ORM1; MMP8; LILRA2;	GO:1904469~positive regulation of tumor necrosis factor secretion	4	22	18.1818181818182	0.00093648118576794	0.0157736914809517	1	1	0.569380560946911	0.99546503601856	0.135476081377016
down	CPTP; PLEKHA3; GLTP;	GO:0035627~ceramide transport	3	9	33.3333333333333	0.00097320888269125	0.0159468738114899	1	1	0.574588786194243	0.99546503601856	0.136963498798194
down	AKR7A2; AKR1B10; AKR1C2;	GO:0044597~daunorubicin metabolic process	3	9	33.3333333333333	0.00097320888269125	0.0159468738114899	1	1	0.574588786194243	0.99546503601856	0.136963498798194
down	AKR7A2; AKR1B10; AKR1C2;	GO:0044598~doxorubicin metabolic process	3	9	33.3333333333333	0.00097320888269125	0.0159468738114899	1	1	0.574588786194243	0.99546503601856	0.136963498798194
down	IGHD; ORM1; SAA1;	GO:0050716~positive regulation of interleukin-1 secretion	3	9	33.3333333333333	0.00097320888269125	0.0159468738114899	1	1	0.574588786194243	0.99546503601856	0.136963498798194
down	RAB25; RAB11A; VAMP2;	GO:0060627~regulation of vesicle-mediated transport	3	9	33.3333333333333	0.00097320888269125	0.0159468738114899	1	1	0.574588786194243	0.99546503601856	0.136963498798194
down	FA2H; MCAT; FADS6; MGLL; ELOVL4;	GO:0006633~fatty acid biosynthetic process	5	40	12.5	0.00099750759893768	0.0162566778962007	1	1	0.578153634839554	0.99546503601856	0.139624324480115
down	KRT6A; KRT6B; KRT16; KRT13; KRT5; EPB42; KRT15; KRT4; CFL1;	GO:0007010~cytoskeleton organization	9	139	6.47482014388489	0.00105873149607527	0.0171616960250911	1	1	0.586966952443816	0.99546503601856	0.147397286809529
down	EGFR; ROR2; NLGN1; TNR;	GO:0051968~positive regulation of synaptic transmission, glutamatergic	4	23	17.3913043478261	0.00108457750971291	0.0174866373892216	1	1	0.590800745601669	0.99546503601856	0.150188122597262
down	AGPAT2; PLD1; PLA2G4D; LIPH; PLA2G2F;	GO:0006654~phosphatidic acid biosynthetic process	5	41	12.1951219512195	0.00110357158036845	0.0176982357170791	1	1	0.593600487678779	0.99546503601856	0.152005484900732
down	SFT2D2; RAB38; RAB11A; VAMP2; CHMP1A; MYO5B; ARF5; AP1S3; NECAP1;	GO:0016192~vesicle-mediated transport	9	141	6.38297872340426	0.00116331833204053	0.0184600251110642	1	1	0.602178785885166	0.99546503601856	0.158548293352154
down	CLDN1; EGFR; GYPA; NCAM1; CXADR; NECTIN4; SLC52A2;	GO:0046718~viral entry into host cell	7	87	8.04597701149425	0.00117226212928323	0.0185045566481096	1	1	0.603545517450751	0.99546503601856	0.158930762994336
down	CA2; CA4; AQP1; HBA1; CYB5R1;	GO:0015701~bicarbonate transport	5	42	11.9047619047619	0.0012177613441462	0.019020995949435	1	1	0.610098433417244	0.99546503601856	0.163366324124533
down	TSPAN15; EGFR; NRARP; CHAC1; NOTCH3;	GO:0045746~negative regulation of Notch signaling pathway	5	42	11.9047619047619	0.0012177613441462	0.019020995949435	1	1	0.610098433417244	0.99546503601856	0.163366324124533
down	CD24; ID1; ROR2; NTRK2;	GO:0043408~regulation of MAPK cascade	4	24	16.6666666666667	0.00124835064279916	0.019020995949435	1	1	0.614188516257185	0.99546503601856	0.163366324124533
down	MUC1; HHEX; MAD2L2;	GO:0010944~negative regulation of transcription by competitive promoter binding	3	10	30	0.00124914003250021	0.019020995949435	1	1	0.614364258117374	0.99546503601856	0.163366324124533
down	PSEN2; DHCR24; PSENEN;	GO:0042987~amyloid precursor protein catabolic process	3	10	30	0.00124914003250021	0.019020995949435	1	1	0.614364258117374	0.99546503601856	0.163366324124533
down	TGFA; ADORA1; EPGN;	GO:0045741~positive regulation of epidermal growth factor-activated receptor activity	3	10	30	0.00124914003250021	0.019020995949435	1	1	0.614364258117374	0.99546503601856	0.163366324124533
down	PSCA; SLURP1; LYPD6B;	GO:0099601~regulation of neurotransmitter receptor activity	3	10	30	0.00124914003250021	0.019020995949435	1	1	0.614364258117374	0.99546503601856	0.163366324124533
down	CLDN5; PF4; EFNA3; HHEX; FOXC1; SPINK5; PLK2;	GO:0016525~negative regulation of angiogenesis	7	89	7.86516853932584	0.00132571237043844	0.0200855416928236	1	1	0.624410526476504	0.99546503601856	0.172509427115677
down	SCEL; EGFR; JUP; PSMC3; PSMB6; ROR2; BAMBI; NRARP; CCAR2;	GO:0090263~positive regulation of canonical Wnt signaling pathway	9	144	6.25	0.00133569562693958	0.0201356115761142	1	1	0.625194113924635	0.99546503601856	0.172939464154972
down	FUT3; DAD1; FUT2; FUT7; ST6GALNAC5; B3GNT3; B3GNT8;	GO:0006486~protein glycosylation	7	90	7.77777777777778	0.00140809695858624	0.0211214543787935	1	1	0.631785238793065	0.99546503601856	0.181406608318532
down	SULT2B1; CYP2E1; SULT1E1; AKR1C2; DHCR24;	GO:0008202~steroid metabolic process	5	44	11.3636363636364	0.00147201754033677	0.0218627235670707	1	1	0.63738359496582	0.99546503601856	0.1877731741281
down	AKR1B10; LRAT; ALDH1A3; SDR16C5; ADH7;	GO:0042572~retinol metabolic process	5	44	11.3636363636364	0.00147201754033677	0.0218627235670707	1	1	0.63738359496582	0.99546503601856	0.1877731741281
down	EFNA5; EPHB3; FUT7;	GO:0022407~regulation of cell-cell adhesion	3	11	27.2727272727273	0.0015696870905586	0.022752916240549	1	1	0.646130628212591	0.99546503601856	0.195418804525969
down	FUT3; FUT2; FUT7;	GO:0036065~fucosylation	3	11	27.2727272727273	0.0015696870905586	0.022752916240549	1	1	0.646130628212591	0.99546503601856	0.195418804525969
down	JUP; DSP; DSC2;	GO:0098911~regulation of ventricular cardiac muscle cell action potential	3	11	27.2727272727273	0.0015696870905586	0.022752916240549	1	1	0.646130628212591	0.99546503601856	0.195418804525969
down	CCNB1; KLF5; IL18; PLA2G4F; P2RY13;	GO:0071407~cellular response to organic cyclic compound	5	45	11.1111111111111	0.00161284264882755	0.0232666056756702	1	1	0.649975587477503	0.99546503601856	0.199830747779648
up	DVL1; TBX1; WNT5A; SOX9; PTK7; FZD2; SIX1; VANGL2;	GO:0090103~cochlea morphogenesis	8	24	33.3333333333333	0.00164831025113354	0.276202301776549	1	1	0.999999845920836	0.999999845920836	1
down	DAD1; DOLPP1; ALG8; MGAT4B; PMM1;	GO:0006487~protein N-linked glycosylation	5	46	10.8695652173913	0.00176331007325681	0.0248428965928471	1	1	0.663093081918112	0.99546503601856	0.213369095275996
down	GJB6; CXCL14; GJB2; MPV17; KCNQ1;	GO:0048839~inner ear development	5	46	10.8695652173913	0.00176331007325681	0.0248428965928471	1	1	0.663093081918112	0.99546503601856	0.213369095275996
down	CLDN5; RAMP1; RAMP2; BAMBI; TRIB3; PLK2;	GO:0032092~positive regulation of protein binding	6	70	8.57142857142857	0.00193596660415318	0.026429543651865	1	1	0.678627507896188	0.99546503601856	0.226996388946833
down	MIF4GD; EIF4A3; EIF6; KRT17; PLD1; TARBP2;	GO:0045727~positive regulation of translation	6	70	8.57142857142857	0.00193596660415318	0.026429543651865	1	1	0.678627507896188	0.99546503601856	0.226996388946833
down	SHMT2; SLC25A23; COX7A2;	GO:0002082~regulation of oxidative phosphorylation	3	12	25	0.0019372899326906	0.026429543651865	1	1	0.678627507896188	0.99546503601856	0.226996388946833
down	ADH7; ALDH3B2; SULT1E1;	GO:0006068~ethanol catabolic process	3	12	25	0.0019372899326906	0.026429543651865	1	1	0.678627507896188	0.99546503601856	0.226996388946833
down	LTF; PLN; TNNT2;	GO:0032780~negative regulation of ATPase activity	3	12	25	0.0019372899326906	0.026429543651865	1	1	0.678627507896188	0.99546503601856	0.226996388946833
down	SCD; SCD5; PPT2;	GO:0046949~fatty-acyl-CoA biosynthetic process	3	12	25	0.0019372899326906	0.026429543651865	1	1	0.678627507896188	0.99546503601856	0.226996388946833
down	RAB27B; F13A1; ORM1; PF4; CD9; CTSW; ECM1; CYB5R1;	GO:0002576~platelet degranulation	8	124	6.45161290322581	0.00201934357819966	0.02742486886609	1	1	0.686168583823026	0.99546503601856	0.235544975045514
down	NUPR1; GSTP1; CD300A; MED31;	GO:0048147~negative regulation of fibroblast proliferation	4	28	14.2857142857143	0.0020772336600039	0.0278349310440522	1	1	0.691321465063645	0.99546503601856	0.239066891082627
down	ATP6V0E1; RAB38; ATP6V1C2; SLAMF8;	GO:0090383~phagosome acidification	4	28	14.2857142857143	0.0020772336600039	0.0278349310440522	1	1	0.691321465063645	0.99546503601856	0.239066891082627
down	SYNGR1; LRAT; RARG; KLF5; BSPRY; PMM1; MYNN;	GO:1990830~cellular response to leukemia inhibitory factor	7	97	7.21649484536082	0.00210237729154072	0.0280472014778552	1	1	0.693621476666601	0.99546503601856	0.240890025927034
down	CLDN1; ASS1; TCL1A; LCN2; OCLN; NPNT; CCL26; XCL1;	GO:0071356~cellular response to tumor necrosis factor	8	125	6.4	0.00211705617824276	0.0281186095920789	1	1	0.694400925043158	0.99546503601856	0.241503331411373
up	PDLIM1; PAK4; CDH2; SHC1; SOX9; SCRIB; FAT1; CNN3; NLGN2; FBLIM1; ROPN1B; TENM2; CDH11; LAMA3; ARVCF; CELSR1; CDH13; CDH3; FAT2; FAT4; COL16A1; DSG2; LAMA5; ICOS;	GO:0098609~cell-cell adhesion	24	152	15.7894736842105	0.00212498755631918	0.329291340938845	1	1	0.999999845920836	0.999999845920836	1
down	FUT2; IL18; KIF14; LMO7; SPINK5;	GO:0030155~regulation of cell adhesion	5	49	10.2040816326531	0.00227644170311725	0.0295749334319532	1	1	0.703297805036516	0.99546503601856	0.254011313279812
down	MPZL2; KRT18; CST6; SIAH1; PHLDA3; FOXQ1; FOXC1; PITX1;	GO:0009653~anatomical structure morphogenesis	8	127	6.2992125984252	0.00232360703044832	0.0295749334319532	1	1	0.70548459305903	0.99546503601856	0.254011313279812
down	EGFR; ERBB3; FGFR3; MATK; EPHB3; ROR2; MST1R; NTRK2;	GO:0018108~peptidyl-tyrosine phosphorylation	8	127	6.2992125984252	0.00232360703044832	0.0295749334319532	1	1	0.70548459305903	0.99546503601856	0.254011313279812
down	ORM1; BPI; NLRX1; IL36RN;	GO:0032715~negative regulation of interleukin-6 production	4	29	13.7931034482759	0.00233210788263927	0.0295749334319532	1	1	0.705932281945529	0.99546503601856	0.254011313279812
down	GRIN2D; ADORA1; FABP5; MGLL;	GO:0051930~regulation of sensory perception of pain	4	29	13.7931034482759	0.00233210788263927	0.0295749334319532	1	1	0.705932281945529	0.99546503601856	0.254011313279812
down	PRMT5; EGFR; GSTP1; FAM83D;	GO:0070372~regulation of ERK1 and ERK2 cascade	4	29	13.7931034482759	0.00233210788263927	0.0295749334319532	1	1	0.705932281945529	0.99546503601856	0.254011313279812
down	MT1G; AOC1; AQP1; MT1X;	GO:0071280~cellular response to copper ion	4	29	13.7931034482759	0.00233210788263927	0.0295749334319532	1	1	0.705932281945529	0.99546503601856	0.254011313279812
down	IGHA1; IGHA2; TMEM63C;	GO:0003094~glomerular filtration	3	13	23.0769230769231	0.00235422355677239	0.0295749334319532	1	1	0.706838318977729	0.99546503601856	0.254011313279812
down	ADRB2; EFNA5; ANGPT1;	GO:0007171~activation of transmembrane receptor protein tyrosine kinase activity	3	13	23.0769230769231	0.00235422355677239	0.0295749334319532	1	1	0.706838318977729	0.99546503601856	0.254011313279812
down	CD19; FCGR2B; IL13RA2;	GO:0016064~immunoglobulin mediated immune response	3	13	23.0769230769231	0.00235422355677239	0.0295749334319532	1	1	0.706838318977729	0.99546503601856	0.254011313279812
down	CA2; HAP1; NLGN1;	GO:0032230~positive regulation of synaptic transmission, GABAergic	3	13	23.0769230769231	0.00235422355677239	0.0295749334319532	1	1	0.706838318977729	0.99546503601856	0.254011313279812
down	CLDN5; RAMP2; ANGPT1;	GO:0043116~negative regulation of vascular permeability	3	13	23.0769230769231	0.00235422355677239	0.0295749334319532	1	1	0.706838318977729	0.99546503601856	0.254011313279812
down	RAMP1; RAMP2; PLN; BSPRY; NMUR1; PSEN2;	GO:0006816~calcium ion transport	6	74	8.10810810810811	0.00251295440080923	0.031437998001825	1	1	0.714639451390569	0.99546503601856	0.270012684143658
up	LRP4; APP; SHANK2; SHANK3;	GO:0051124~synaptic growth at neuromuscular junction	4	5	80	0.00258520855825384	0.381366233878521	1	1	0.999999845920836	0.999999845920836	1
down	SLC1A7; GIPC1; VAMP2; NTRK2;	GO:0014047~glutamate secretion	4	30	13.3333333333333	0.00260769805312089	0.0324884695461135	1	1	0.719510863370834	0.99546503601856	0.279034907545842
down	ALOX15B; ALOX15; IL1RN; ALDH3B2; FABP5; MGLL; MGST2; EPHX3;	GO:0006629~lipid metabolic process	8	130	6.15384615384615	0.00266268374125866	0.0327313520550639	1	1	0.721802150321193	0.99546503601856	0.28112096144054
down	CLDN4; EGFR; ASS1; NTRK2; ARNTL2; PROK2;	GO:0007623~circadian rhythm	6	75	8	0.00267544853555823	0.0327313520550639	1	1	0.722387873449269	0.99546503601856	0.28112096144054
up	NEFL; ARHGDIA; ROBO1; MAP6; PLXNA2; PLXNB3; PLXNB1; PLXNA1; PLXNB2;	GO:0050772~positive regulation of axonogenesis	9	33	27.2727272727273	0.00273322550731225	0.381366233878521	1	1	0.999999845920836	0.999999845920836	1
up	NRP1; TBX1; FN1; PDGFA; SERPINE1; ITGAV; MMP2; COL4A2; CCL2; SHC1; MYH9; MCAM; MMP14; VAV2; EPHB4; RHOB; JAG1; HSPG2; CAV1; MFGE8; DAB2IP; CSPG4; PLCD3; ANGPTL4; POFUT1; TNFRSF12A; ESM1; EGFL7; APLN; AMOTL1; PGF; VEGFC;	GO:0001525~angiogenesis	32	230	13.9130434782609	0.00274500391721944	0.381366233878521	1	1	0.999999845920836	0.999999845920836	1
down	GPRC5A; VPS25; CBLC;	GO:0007175~negative regulation of epidermal growth factor-activated receptor activity	3	14	21.4285714285714	0.00282260415731894	0.0327313520550639	1	1	0.728771978369359	0.99546503601856	0.28112096144054
down	HBD; HBA1; HBM;	GO:0015671~oxygen transport	3	14	21.4285714285714	0.00282260415731894	0.0327313520550639	1	1	0.728771978369359	0.99546503601856	0.28112096144054
down	CD24; PPP1R14C; PPP1R14A;	GO:0042325~regulation of phosphorylation	3	14	21.4285714285714	0.00282260415731894	0.0327313520550639	1	1	0.728771978369359	0.99546503601856	0.28112096144054
down	SAA1; AZU1; CXCL17;	GO:0048246~macrophage chemotaxis	3	14	21.4285714285714	0.00282260415731894	0.0327313520550639	1	1	0.728771978369359	0.99546503601856	0.28112096144054
down	CLDN5; TJP1; OCLN;	GO:2000810~regulation of bicellular tight junction assembly	3	14	21.4285714285714	0.00282260415731894	0.0327313520550639	1	1	0.728771978369359	0.99546503601856	0.28112096144054
down	PF4; JUP; TAL1; FUT3; ERBB3; PLCD1; FA2H; ANXA1; PTK6;	GO:0042127~regulation of cell population proliferation	9	163	5.52147239263804	0.00296231123941981	0.0340891923162242	1	1	0.732829038219907	0.99546503601856	0.292783093791745
down	DKK1; SLPI; ID1; CARD18; CTNNBIP1; STUB1;	GO:0032091~negative regulation of protein binding	6	77	7.79220779220779	0.0030239019579148	0.034534334860277	1	1	0.734154130506577	0.99546503601856	0.296606305853126
down	EFNA5; ARHGEF19; GRHL3; RND3; RHOD; RHOV;	GO:0032956~regulation of actin cytoskeleton organization	6	77	7.79220779220779	0.0030239019579148	0.034534334860277	1	1	0.734154130506577	0.99546503601856	0.296606305853126
down	S100B; GSTP1; PTPRZ1; ZBTB16; GRHL3; KLK6; SPINK5; SPINK6;	GO:0007417~central nervous system development	8	133	6.01503759398496	0.00303921204254143	0.0345782049368393	1	1	0.73442631162492	0.99546503601856	0.296983094385445
down	ANXA1; ALOX15; XCL1; DUOXA1; DUOXA2; MGLL;	GO:0050727~regulation of inflammatory response	6	78	7.69230769230769	0.00321031496007262	0.0361380107480921	1	1	0.737894676732948	0.99546503601856	0.310379855649149
down	LILRA5; MAPK13; EGFR; IL18; NLRP10; MGST2;	GO:0050729~positive regulation of inflammatory response	6	78	7.69230769230769	0.00321031496007262	0.0361380107480921	1	1	0.737894676732948	0.99546503601856	0.310379855649149
down	SLC6A15; SLC6A14; SLC6A11; TMEM184A;	GO:0006810~transport	4	32	12.5	0.00322425369526924	0.0361380107480921	1	1	0.738201685127678	0.99546503601856	0.310379855649149
down	EGFR; KCNA5; UBE2E2; ANXA1;	GO:1900087~positive regulation of G1/S transition of mitotic cell cycle	4	32	12.5	0.00322425369526924	0.0361380107480921	1	1	0.738201685127678	0.99546503601856	0.310379855649149
down	XCL1; IL20RB; TBX21;	GO:0032703~negative regulation of interleukin-2 production	3	15	20	0.00334439502136819	0.0369353516096157	1	1	0.740435855128929	0.99546503601856	0.317228006291086
down	PLA2G4D; PLA2G4F; PLA2G4E;	GO:0046475~glycerophospholipid catabolic process	3	15	20	0.00334439502136819	0.0369353516096157	1	1	0.740435855128929	0.99546503601856	0.317228006291086
down	KRT1; KRT10; FARSA;	GO:0051290~protein heterotetramerization	3	15	20	0.00334439502136819	0.0369353516096157	1	1	0.740435855128929	0.99546503601856	0.317228006291086
down	AZU1; PRSS33; ADGRG1;	GO:0070528~protein kinase C signaling	3	15	20	0.00334439502136819	0.0369353516096157	1	1	0.740435855128929	0.99546503601856	0.317228006291086
down	ERBB3; PTPRZ1; KIF14; ANGPT1; NTRK2; UNC5B; FOXQ1; BOK;	GO:0043524~negative regulation of neuron apoptotic process	8	138	5.79710144927536	0.00375738529899583	0.041344951373987	1	1	0.748402628454655	0.99546503601856	0.355100897189165
down	NUPR1; PSEN2; DAD1; WRNIP1; MGST2; PSENEN;	GO:0043085~positive regulation of catalytic activity	6	81	7.40740740740741	0.0038210442841633	0.0414639578264003	1	1	0.749462865511632	0.99546503601856	0.356123012262926
down	PTGES; PLA2G4F; MGST1;	GO:0001516~prostaglandin biosynthetic process	3	16	18.75	0.00392141225011489	0.0414639578264003	1	1	0.751310707239507	0.99546503601856	0.356123012262926
down	HRH2; RAB25; POF1B;	GO:0003382~epithelial cell morphogenesis	3	16	18.75	0.00392141225011489	0.0414639578264003	1	1	0.751310707239507	0.99546503601856	0.356123012262926
down	ASTN1; NLGN1; TNR;	GO:0007158~neuron cell-cell adhesion	3	16	18.75	0.00392141225011489	0.0414639578264003	1	1	0.751310707239507	0.99546503601856	0.356123012262926
down	CYP2E1; MGST1; MGST2;	GO:0010243~response to organonitrogen compound	3	16	18.75	0.00392141225011489	0.0414639578264003	1	1	0.751310707239507	0.99546503601856	0.356123012262926
down	CSTA; CSTB; ECM1;	GO:0010466~negative regulation of peptidase activity	3	16	18.75	0.00392141225011489	0.0414639578264003	1	1	0.751310707239507	0.99546503601856	0.356123012262926
down	PMVK; CYB5R1; TM7SF2;	GO:0016126~sterol biosynthetic process	3	16	18.75	0.00392141225011489	0.0414639578264003	1	1	0.751310707239507	0.99546503601856	0.356123012262926
down	FCGR2B; MNDA; CD300A;	GO:0030889~negative regulation of B cell proliferation	3	16	18.75	0.00392141225011489	0.0414639578264003	1	1	0.751310707239507	0.99546503601856	0.356123012262926
down	AQP1; RHOD; RND3;	GO:0030950~establishment or maintenance of actin cytoskeleton polarity	3	16	18.75	0.00392141225011489	0.0414639578264003	1	1	0.751310707239507	0.99546503601856	0.356123012262926
down	UPK3A; KCNA5; SLC12A1;	GO:0055075~potassium ion homeostasis	3	16	18.75	0.00392141225011489	0.0414639578264003	1	1	0.751310707239507	0.99546503601856	0.356123012262926
down	AQP1; RAB11A; CYP4F12; MYO5B;	GO:0003091~renal water homeostasis	4	34	11.7647058823529	0.00393323115699851	0.0414639578264003	1	1	0.751310707239507	0.99546503601856	0.356123012262926
down	OVOL1; KRT9; DHCR24; DSP;	GO:0043588~skin development	4	34	11.7647058823529	0.00393323115699851	0.0414639578264003	1	1	0.751310707239507	0.99546503601856	0.356123012262926
up	NOTCH1; SOX9; DLX1; SOX8;	GO:0046533~negative regulation of photoreceptor cell differentiation	4	6	66.6666666666667	0.00406220582690042	0.495958402320661	1	1	0.999999845920836	0.999999845920836	1
up	MYO1C; ADAMTS3; CCBE1; ROBO1;	GO:1900748~positive regulation of vascular endothelial growth factor signaling pathway	4	6	66.6666666666667	0.00406220582690042	0.495958402320661	1	1	0.999999845920836	0.999999845920836	1
down	EGFR; TGFA; ID1; EPGN; ESRP2;	GO:0050679~positive regulation of epithelial cell proliferation	5	57	8.7719298245614	0.00416641480784463	0.0418126221937609	1	1	0.75457628271917	0.99546503601856	0.35911759867682
down	S100B; CCNB1; AQP1; EIF4EBP1; ENDOG; STUB1; HILPDA;	GO:0071456~cellular response to hypoxia	7	111	6.30630630630631	0.00425627360073455	0.0424922679013731	1	1	0.755882908316952	0.99546503601856	0.364954896642435
up	COL4A1; COL4A5; DDR1; COL4A6; COL4A2;	GO:0038063~collagen-activated tyrosine kinase receptor signaling pathway	5	11	45.4545454545455	0.00443494099033992	0.510525064287987	1	1	0.999999845920836	0.999999845920836	1
up	INHBA; ITGB4; ITGA2; ITGA3; HMGA2;	GO:0048333~mesodermal cell differentiation	5	11	45.4545454545455	0.00443494099033992	0.510525064287987	1	1	0.999999845920836	0.999999845920836	1
down	ALOX15B; PF4; IL18;	GO:0010744~positive regulation of macrophage derived foam cell differentiation	3	17	17.6470588235294	0.00455533031114741	0.0448834015951289	1	1	0.759826117710258	0.99546503601856	0.385491714119167
down	CTSV; GRHL1; SERPINB13;	GO:0045616~regulation of keratinocyte differentiation	3	17	17.6470588235294	0.00455533031114741	0.0448834015951289	1	1	0.759826117710258	0.99546503601856	0.385491714119167
down	CHMP1B; CHMP4C; CHMP1A;	GO:0061952~midbody abscission	3	17	17.6470588235294	0.00455533031114741	0.0448834015951289	1	1	0.759826117710258	0.99546503601856	0.385491714119167
down	CEACAM6; TLE1; NTRK2;	GO:2000811~negative regulation of anoikis	3	17	17.6470588235294	0.00455533031114741	0.0448834015951289	1	1	0.759826117710258	0.99546503601856	0.385491714119167
down	SLC9A3R1; GJB6; GJB2; KCNQ1; USH1G; ESPNL; TIMM13; MYO7B;	GO:0007605~sensory perception of sound	8	143	5.59440559440559	0.00460012364580931	0.045177110072036	1	1	0.760212706866465	0.99546503601856	0.388014298865207
down	DKK1; EGFR; S100B; GM2A; PTPRZ1;	GO:0007611~learning or memory	5	59	8.47457627118644	0.00477445343037686	0.0467369386122929	1	1	0.762642695848335	0.99546503601856	0.40141125534234
up	GLI3; PAX6; NOTCH1; VEGFC; DMRTA2; SMO; DCT;	GO:0002052~positive regulation of neuroblast proliferation	7	23	30.4347826086957	0.00483605120726027	0.541234730945879	1	1	0.999999845920836	0.999999845920836	1
down	ARPC2; PSEN2; EFNA3; EFNA5; EPHB3; PSENEN;	GO:0048013~ephrin receptor signaling pathway	6	86	6.97674418604651	0.00502441176096613	0.0490246001919511	1	1	0.765740931800219	0.99546503601856	0.421059378085397
down	EPCAM; SDC4; FOXC1; NPNT;	GO:0001657~ureteric bud development	4	37	10.8108108108108	0.00518328683020663	0.0496114596605492	1	1	0.767616061929028	0.99546503601856	0.426099759483796
down	FOXN1; DKK1; EGFR; NSDHL;	GO:0001942~hair follicle development	4	37	10.8108108108108	0.00518328683020663	0.0496114596605492	1	1	0.767616061929028	0.99546503601856	0.426099759483796
down	ETHE1; GSTP1; MGST1; PTGES;	GO:0006749~glutathione metabolic process	4	37	10.8108108108108	0.00518328683020663	0.0496114596605492	1	1	0.767616061929028	0.99546503601856	0.426099759483796
down	ASS1; ORM1; SAA1; SAA2;	GO:0006953~acute-phase response	4	37	10.8108108108108	0.00518328683020663	0.0496114596605492	1	1	0.767616061929028	0.99546503601856	0.426099759483796
down	ALOX15; ARL2; NPNT; FBLN2;	GO:0010811~positive regulation of cell-substrate adhesion	4	37	10.8108108108108	0.00518328683020663	0.0496114596605492	1	1	0.767616061929028	0.99546503601856	0.426099759483796
down	CLDN7; CRYAB; EIF4EBP1; CTNNBIP1;	GO:0031333~negative regulation of protein-containing complex assembly	4	37	10.8108108108108	0.00518328683020663	0.0496114596605492	1	1	0.767616061929028	0.99546503601856	0.426099759483796
down	CES2; PTGES; AKR1C2;	GO:0006693~prostaglandin metabolic process	3	18	16.6666666666667	0.00524768742569726	0.0497540175738278	1	1	0.768531934933567	0.99546503601856	0.427324151851529
down	NPNT; PROK2; NMU;	GO:0045987~positive regulation of smooth muscle contraction	3	18	16.6666666666667	0.00524768742569726	0.0497540175738278	1	1	0.768531934933567	0.99546503601856	0.427324151851529
down	SULT2B1; SULT1E1; ABHD14B;	GO:0050427~3'-phosphoadenosine 5'-phosphosulfate metabolic process	3	18	16.6666666666667	0.00524768742569726	0.0497540175738278	1	1	0.768531934933567	0.99546503601856	0.427324151851529
down	SLC9A3R1; DKK1; PSMC3; IGFBP2; PSMB6; ROR2; MAD2L2; RUVBL2; TLE1;	GO:0090090~negative regulation of canonical Wnt signaling pathway	9	179	5.02793296089385	0.00529481638452456	0.0498887839002938	1	1	0.769000123745589	0.99546503601856	0.428481624332416
down	ERBB3; IL18; ANGPT1; NTRK2; UNC5B; ROR2;	GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling	6	87	6.89655172413793	0.00529499530616717	0.0498887839002938	1	1	0.769000123745589	0.99546503601856	0.428481624332416
up	PLXNB2; CLSTN1; CDH13; DSG2; FAT1; SDK2; FAT4; CELSR1; FAT2; TENM3; CD84; PLXNB3; PCDHGC3; IGSF9B; PCDHB2; PCDHGB2; ROBO1; BSG; MYOT; PALLD; L1CAM; CDH11; CDH3; CDH2;	GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules	24	165	14.5454545454545	0.00534799206556269	0.567027895582949	1	1	0.999999845920836	0.999999845920836	1
down	CLUH; RAB38; CXADR; ADGRG6; MIEF2; CHCHD2;	GO:0007005~mitochondrion organization	6	88	6.81818181818182	0.00557609075024967	0.0516937345362611	1	1	0.77248389089016	0.99546503601856	0.443983869925027
down	EGFR; TXN; TCL1A; ANGPT1; NTRK2; MAD2L2;	GO:0033138~positive regulation of peptidyl-serine phosphorylation	6	88	6.81818181818182	0.00557609075024967	0.0516937345362611	1	1	0.77248389089016	0.99546503601856	0.443983869925027
down	DKK1; C1QA; ADORA1; FCGR2B;	GO:1901216~positive regulation of neuron death	4	38	10.5263157894737	0.00565264368820184	0.0516937345362611	1	1	0.773550918998439	0.99546503601856	0.443983869925027
down	MRPL12; MRPL49; GADD45GIP1; CHCHD1; MRPL11; MRPS18B;	GO:0070125~mitochondrial translational elongation	6	89	6.74157303370786	0.00586792998563412	0.0521882268633831	1	1	0.775790796184415	0.99546503601856	0.448230934274574
down	MRPL12; MRPL49; GADD45GIP1; CHCHD1; MRPL11; MRPS18B;	GO:0070126~mitochondrial translational termination	6	89	6.74157303370786	0.00586792998563412	0.0521882268633831	1	1	0.775790796184415	0.99546503601856	0.448230934274574
down	PSMC3; DAD1; ELF3;	GO:0001824~blastocyst development	3	19	15.7894736842105	0.00599989079474539	0.0524122960904749	1	1	0.777570359626663	0.99546503601856	0.450155405846763
down	ALOX12B; SERINC3; SPNS2;	GO:0006665~sphingolipid metabolic process	3	19	15.7894736842105	0.00599989079474539	0.0524122960904749	1	1	0.777570359626663	0.99546503601856	0.450155405846763
down	MAPK13; EGFR; MAP7;	GO:0006970~response to osmotic stress	3	19	15.7894736842105	0.00599989079474539	0.0524122960904749	1	1	0.777570359626663	0.99546503601856	0.450155405846763
down	MYO5B; MYO7B; MYO1B;	GO:0030050~vesicle transport along actin filament	3	19	15.7894736842105	0.00599989079474539	0.0524122960904749	1	1	0.777570359626663	0.99546503601856	0.450155405846763
down	RARG; PTPRZ1; KIF14;	GO:0031641~regulation of myelination	3	19	15.7894736842105	0.00599989079474539	0.0524122960904749	1	1	0.777570359626663	0.99546503601856	0.450155405846763
down	FOLR2; SHMT2; FPGS;	GO:0046655~folic acid metabolic process	3	19	15.7894736842105	0.00599989079474539	0.0524122960904749	1	1	0.777570359626663	0.99546503601856	0.450155405846763
down	SAA1; CD24; BDKRB2; NMU; BCAP31; PROK2; PTGDR; CXCR1;	GO:0007204~positive regulation of cytosolic calcium ion concentration	8	150	5.33333333333333	0.00601481076195831	0.0524122960904749	1	1	0.777570359626663	0.99546503601856	0.450155405846763
down	UCHL1; PSMC3; PSMB6; IFI27; KIF14; SIAH1; FBXW5; TBX21; STUB1;	GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process	9	183	4.91803278688525	0.00605520630712275	0.0526122392391213	1	1	0.778183827366014	0.99546503601856	0.451872664885936
down	GSTP1; UCHL1; CD300A; CBLC;	GO:0043407~negative regulation of MAP kinase activity	4	39	10.2564102564103	0.00614950121972624	0.0532780062571109	1	1	0.779442769857203	0.99546503601856	0.457590762441998
up	SOX9; SOX8; SIX1; SMO; SIX4; MAGED1;	GO:0090190~positive regulation of branching involved in ureteric bud morphogenesis	6	18	33.3333333333333	0.00624553777172809	0.629081792057312	1	1	0.999999845920836	0.999999845920836	1
down	KIF14; NPNT; CHMP1B; NLGN1;	GO:0045184~establishment of protein localization	4	40	10	0.00667453137221685	0.0576610661525324	1	1	0.785695913457305	0.99546503601856	0.495235709396205
down	MT-CO2; COX8A; COX5B;	GO:0006123~mitochondrial electron transport, cytochrome c to oxygen	3	20	15	0.00681322166893561	0.0585238271562418	1	1	0.787232476521433	0.99546503601856	0.502645736407865
down	SYNGR1; TMEM79; RAB11FIP1;	GO:0045055~regulated exocytosis	3	20	15	0.00681322166893561	0.0585238271562418	1	1	0.787232476521433	0.99546503601856	0.502645736407865
up	NRP1; WNT5A; WNT3; SEMA3F; SEMA6D; SEMA7A; SEMA3C;	GO:0048843~negative regulation of axon extension involved in axon guidance	7	25	28	0.00704155409900609	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	PTPRF; LRRC4B; FLRT3; IGSF9B; NTNG1; GPC4; LRFN3;	GO:0099560~synaptic membrane adhesion	7	25	28	0.00704155409900609	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
down	RAB11A; MLPH; RAB27B;	GO:0032402~melanosome transport	3	21	14.2857142857143	0.00768884026594319	0.0623076321696497	1	1	0.797854803790837	0.99546503601856	0.53514384102277
down	CHMP1B; CHMP4C; CHMP1A;	GO:0039702~viral budding via host ESCRT complex	3	21	14.2857142857143	0.00768884026594319	0.0623076321696497	1	1	0.797854803790837	0.99546503601856	0.53514384102277
down	CPE; RAB38; HPS6;	GO:0072657~protein localization to membrane	3	21	14.2857142857143	0.00768884026594319	0.0623076321696497	1	1	0.797854803790837	0.99546503601856	0.53514384102277
down	ANXA1; FGFBP1; PLK2;	GO:0090050~positive regulation of cell migration involved in sprouting angiogenesis	3	21	14.2857142857143	0.00768884026594319	0.0623076321696497	1	1	0.797854803790837	0.99546503601856	0.53514384102277
up	TGFB2; JAG1; SOX4; PPP1R13L; SEMA3C;	GO:0003215~cardiac right ventricle morphogenesis	5	13	38.4615384615385	0.00770285305516794	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	FLRT2; COL4A1; CAV2; CAV1; FERMT1;	GO:0071711~basement membrane organization	5	13	38.4615384615385	0.00770285305516794	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	DVL1; WNT5A; EFNB2; NLGN4Y; NLGN2;	GO:0099054~presynapse assembly	5	13	38.4615384615385	0.00770285305516794	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	LRP4; CALCA; MDK; NOTCH1; SOX9; SFRP1;	GO:0030279~negative regulation of ossification	6	19	31.5789473684211	0.00772158794733768	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
down	SLC9A3R1; ABLIM3; CFL1; RND3; POF1B; AMOTL2; RHOV; ARHGEF10L;	GO:0030036~actin cytoskeleton organization	8	157	5.09554140127389	0.00773777772843665	0.0623076321696497	1	1	0.797854803790837	0.99546503601856	0.53514384102277
down	ELANE; USF1; CCAR2; SERPINB13;	GO:0009411~response to UV	4	42	9.52380952380952	0.00781170313768742	0.0623076321696497	1	1	0.798866454006971	0.99546503601856	0.53514384102277
down	RAMP1; RAMP2; CD9; CXCR1;	GO:0031623~receptor internalization	4	42	9.52380952380952	0.00781170313768742	0.0623076321696497	1	1	0.798866454006971	0.99546503601856	0.53514384102277
down	CLDN4; RAMP2; GJB2; DSG1;	GO:0032570~response to progesterone	4	42	9.52380952380952	0.00781170313768742	0.0623076321696497	1	1	0.798866454006971	0.99546503601856	0.53514384102277
down	ALOX15B; NUPR1; CAMK2N1; CHMP1A;	GO:0045786~negative regulation of cell cycle	4	42	9.52380952380952	0.00781170313768742	0.0623076321696497	1	1	0.798866454006971	0.99546503601856	0.53514384102277
down	CTDSPL; CDK2AP2; CDKN2B; GPNMB;	GO:2000134~negative regulation of G1/S transition of mitotic cell cycle	4	42	9.52380952380952	0.00781170313768742	0.0623076321696497	1	1	0.798866454006971	0.99546503601856	0.53514384102277
down	SLC9A3R1; PSCA; GSTP1; CAMK2N1; NDRG2;	GO:0070373~negative regulation of ERK1 and ERK2 cascade	5	67	7.46268656716418	0.00784111891522921	0.0623430795668366	1	1	0.799794129353379	0.99546503601856	0.535448289380448
down	NUPR1; ID1; PMF1; CCAR2; VGLL1; ARL2BP;	GO:1903508~positive regulation of nucleic acid-templated transcription	6	95	6.31578947368421	0.00785750256563778	0.0623430795668366	1	1	0.799900585339019	0.99546503601856	0.535448289380448
down	PHGDH; AKR7A2; COX7A2; MAOB; ME1;	GO:0022900~electron transport chain	5	68	7.35294117647059	0.00830195794961441	0.0656373530024794	1	1	0.805289921112598	0.99546503601856	0.563741936215385
down	AGPAT2; MGST1; IGFBP2; AOC1; AQP1; ALDH3A1; SLC6A11; DAD1; ANXA1;	GO:0042493~response to drug	9	193	4.66321243523316	0.00832420947203716	0.0656373530024794	1	1	0.805436229528216	0.99546503601856	0.563741936215385
down	ACAA1; ACADS; ECHS1; MCAT;	GO:0006635~fatty acid beta-oxidation	4	43	9.30232558139535	0.00842509307196004	0.0656373530024794	1	1	0.80662243899733	0.99546503601856	0.563741936215385
down	CKB; MAOB; DYNLL1; NDRG2;	GO:0021762~substantia nigra development	4	43	9.30232558139535	0.00842509307196004	0.0656373530024794	1	1	0.80662243899733	0.99546503601856	0.563741936215385
down	JUP; DSP; NECTIN4; CDH26;	GO:0034332~adherens junction organization	4	43	9.30232558139535	0.00842509307196004	0.0656373530024794	1	1	0.80662243899733	0.99546503601856	0.563741936215385
down	SDC4; GPNMB; IL20RB; PLA2G2F;	GO:0042130~negative regulation of T cell proliferation	4	43	9.30232558139535	0.00842509307196004	0.0656373530024794	1	1	0.80662243899733	0.99546503601856	0.563741936215385
down	EGFR; GSTP1; ID1; FOXC1;	GO:0071364~cellular response to epidermal growth factor stimulus	4	43	9.30232558139535	0.00842509307196004	0.0656373530024794	1	1	0.80662243899733	0.99546503601856	0.563741936215385
up	PAX6; WNT3; SFRP1; MDFI;	GO:0009950~dorsal/ventral axis specification	4	8	50	0.00851533442397789	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	F2; PDGFB; PDGFA; C1QTNF1;	GO:0010544~negative regulation of platelet activation	4	8	50	0.00851533442397789	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	NRP1; SLIT1; SLIT3; SEMA3F;	GO:0048846~axon extension involved in axon guidance	4	8	50	0.00851533442397789	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
down	SCD; ADRB2; LCN2; FABP5; IL18; PEMT;	GO:0120162~positive regulation of cold-induced thermogenesis	6	97	6.18556701030928	0.00861705111216649	0.0660223057764954	1	1	0.809081653750371	0.99546503601856	0.567048194195761
down	SFN; TIMM50; BOK;	GO:0001836~release of cytochrome c from mitochondria	3	22	13.6363636363636	0.00862779053928331	0.0660223057764954	1	1	0.809081653750371	0.99546503601856	0.567048194195761
down	SLC9A3R1; RARG; MTPN;	GO:0008361~regulation of cell size	3	22	13.6363636363636	0.00862779053928331	0.0660223057764954	1	1	0.809081653750371	0.99546503601856	0.567048194195761
down	NCR3; PRDX1; IL18;	GO:0030101~natural killer cell activation	3	22	13.6363636363636	0.00862779053928331	0.0660223057764954	1	1	0.809081653750371	0.99546503601856	0.567048194195761
down	CCNB1; ADAM15; KLK6;	GO:0042246~tissue regeneration	3	22	13.6363636363636	0.00862779053928331	0.0660223057764954	1	1	0.809081653750371	0.99546503601856	0.567048194195761
down	CSTA; CSTB; CAMK2N1;	GO:0045861~negative regulation of proteolysis	3	22	13.6363636363636	0.00862779053928331	0.0660223057764954	1	1	0.809081653750371	0.99546503601856	0.567048194195761
down	GSTP1; MGST1; MGST2;	GO:1901687~glutathione derivative biosynthetic process	3	22	13.6363636363636	0.00862779053928331	0.0660223057764954	1	1	0.809081653750371	0.99546503601856	0.567048194195761
down	SLC9A3R1; GPAA1; NUPR1; CCNB1; VAMP2; OCLN; NFE4;	GO:0065003~protein-containing complex assembly	7	128	5.46875	0.0087376455751661	0.0665210292664362	1	1	0.810356802140836	0.99546503601856	0.57133159888828
down	FGFR3; PTK6; IL18; STAP2; ARL2BP;	GO:0042531~positive regulation of tyrosine phosphorylation of STAT protein	5	69	7.2463768115942	0.00878121713036206	0.0665210292664362	1	1	0.810356802140836	0.99546503601856	0.57133159888828
down	NUPR1; ID1; XCL1; CTNNBIP1; MAD2L2;	GO:0043433~negative regulation of DNA-binding transcription factor activity	5	69	7.2463768115942	0.00878121713036206	0.0665210292664362	1	1	0.810356802140836	0.99546503601856	0.57133159888828
down	RNASE1; RNASE2; ENDOU; ENDOG; RPP25;	GO:0090502~RNA phosphodiester bond hydrolysis, endonucleolytic	5	69	7.2463768115942	0.00878121713036206	0.0665210292664362	1	1	0.810356802140836	0.99546503601856	0.57133159888828
down	ANXA1; FOLR2; CCL26; XCL1;	GO:0002548~monocyte chemotaxis	4	44	9.09090909090909	0.00906915146249498	0.0683587291485559	1	1	0.814378423987689	0.99546503601856	0.587115119130022
down	ALOX15; FGFR3; ROR2; GPNMB;	GO:0030282~bone mineralization	4	44	9.09090909090909	0.00906915146249498	0.0683587291485559	1	1	0.814378423987689	0.99546503601856	0.587115119130022
down	RARG; HHEX; ZBTB16; CTNNBIP1; HES6; HES2;	GO:0009952~anterior/posterior pattern specification	6	99	6.06060606060606	0.00942778499121066	0.0688554701574727	1	1	0.81872177558229	0.99546503601856	0.591381496815206
down	TK1; CKB; CKMT1A; PMVK; ITPKC; TOLLIP;	GO:0016310~phosphorylation	6	99	6.06060606060606	0.00942778499121066	0.0688554701574727	1	1	0.81872177558229	0.99546503601856	0.591381496815206
up	WNT9A; SNAI2; PTHLH; SOX9; EFEMP1; ADAMTS7;	GO:0032331~negative regulation of chondrocyte differentiation	6	20	30	0.00943298239522206	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	TBX1; COL4A1; NR2F2; EFNB2; CDH2; LAMA1;	GO:0048514~blood vessel morphogenesis	6	20	30	0.00943298239522206	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
down	RAMP2; CRYAB; USF1; KCNA5; CD24; ADORA1; ALDH3A1; PSEN2;	GO:0001666~response to hypoxia	8	163	4.9079754601227	0.00948917218484535	0.0688554701574727	1	1	0.81872177558229	0.99546503601856	0.591381496815206
down	AZU1; BCAP31; DEFB1;	GO:0035584~calcium-mediated signaling using intracellular calcium source	3	23	13.0434782608696	0.00963100480279611	0.0688554701574727	1	1	0.820247818034447	0.99546503601856	0.591381496815206
down	IGFBP2; CD24; IL18;	GO:0042104~positive regulation of activated T cell proliferation	3	23	13.0434782608696	0.00963100480279611	0.0688554701574727	1	1	0.820247818034447	0.99546503601856	0.591381496815206
down	CHMP1B; CHMP4C; CHMP1A;	GO:1901673~regulation of mitotic spindle assembly	3	23	13.0434782608696	0.00963100480279611	0.0688554701574727	1	1	0.820247818034447	0.99546503601856	0.591381496815206
up	DVL1; COL4A1; TNC; COL4A5; LAMB2; AGRN; PPFIBP1; CACNB4;	GO:0007528~neuromuscular junction development	8	34	23.5294117647059	0.00969697890171295	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
down	CDH16; DSG1; NLGN1; CDH26;	GO:0016339~calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules	4	45	8.88888888888889	0.00974445225557363	0.0691282907071871	1	1	0.821815669868855	0.99546503601856	0.593724680656417
down	CTDSPL; CCNB1; IGFBP3; ANGPT1; OCLN;	GO:0001933~negative regulation of protein phosphorylation	5	71	7.04225352112676	0.00979637453957927	0.0693334958611068	1	1	0.822895461324658	0.99546503601856	0.595487133672884
up	WNT5A; TP63; CELSR1; VANGL2; PTK7;	GO:0001736~establishment of planar polarity	5	14	35.7142857142857	0.00983895004490998	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	ITGA2; CTTN; PTPRK; TRIP6; FERMT2; AJUBA; DLC1;	GO:0048041~focal adhesion assembly	7	27	25.9259259259259	0.00991529394856405	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	SH3PXD2B; TBX3; TLL1; ALPL; COL5A2; PTHLH; BMP1; GNA11; SOX9; CDH11; EVC; TGFB2; SOX4; EXT1; ALX4; TP63; JAG2; MMP16; HOXC4; MMP14;	GO:0001501~skeletal system development	20	137	14.5985401459854	0.00998600565264529	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
down	TSPAN15; LTF; CTSG; SAA1; IGFBP3; IGFBP2; MSLN; SIAH1; PSENEN;	GO:0044267~cellular protein metabolic process	9	200	4.5	0.0102608829333655	0.0724509649744658	1	1	0.828541527013562	0.99546503601856	0.622262254753563
down	ADRB2; ANGPT1; NSMCE3; NDFIP2; STUB1;	GO:0031398~positive regulation of protein ubiquitination	5	72	6.94444444444444	0.0103329485599088	0.0727893455797317	1	1	0.828541527013562	0.99546503601856	0.625168516643544
down	SAA1; SAA2; GPNMB; ANGPT1;	GO:0050918~positive chemotaxis	4	46	8.69565217391304	0.0104515487430124	0.073453192214877	1	1	0.830346628379604	0.99546503601856	0.63087012053718
up	CD4; CAV1; DBN1;	GO:0032507~maintenance of protein location in cell	3	4	75	0.0106785743838793	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	TGFB2; SOX4; HES1;	GO:0035910~ascending aorta morphogenesis	3	4	75	0.0106785743838793	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	SOX9; SOX8; FOXD1;	GO:0090184~positive regulation of kidney development	3	4	75	0.0106785743838793	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
down	PF4; BATF; GBP6;	GO:0042832~defense response to protozoan	3	24	12.5	0.0106993082143479	0.0748455087384201	1	1	0.834120931235875	0.99546503601856	0.642828360425025
down	CXCL14; IL18; CMTM5;	GO:0045662~negative regulation of myoblast differentiation	3	24	12.5	0.0106993082143479	0.0748455087384201	1	1	0.834120931235875	0.99546503601856	0.642828360425025
down	PF4; SAA1; PF4V1; GP9; CD9; ENTPD2;	GO:0030168~platelet activation	6	102	5.88235294117647	0.0107437204749603	0.0749822158148271	1	1	0.834120931235875	0.99546503601856	0.644002501495966
down	CEACAM6; CXADR; NLGN1; NECTIN4;	GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules	4	47	8.51063829787234	0.0111909733106603	0.0775650219118181	1	1	0.839322998299524	0.99546503601856	0.666185542758029
down	DKK1; TLE1; SHISA2; CTNNBIP1;	GO:0030178~negative regulation of Wnt signaling pathway	4	47	8.51063829787234	0.0111909733106603	0.0775650219118181	1	1	0.839322998299524	0.99546503601856	0.666185542758029
down	TGFA; TAL1; BTC; MACC1;	GO:0051781~positive regulation of cell division	4	47	8.51063829787234	0.0111909733106603	0.0775650219118181	1	1	0.839322998299524	0.99546503601856	0.666185542758029
down	CXCL14; AZU1; SAA2; SAA1; CXCR1;	GO:0060326~cell chemotaxis	5	74	6.75675675675676	0.0114657338832735	0.0782709924668993	1	1	0.842400047178663	0.99546503601856	0.672248937904653
up	FN1; COL16A1; FERMT3; FERMT2;	GO:0033622~integrin activation	4	9	44.4444444444444	0.0116022080632401	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	LRP5; MEGF8; NODAL; MIXL1;	GO:0042074~cell migration involved in gastrulation	4	9	44.4444444444444	0.0116022080632401	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	FBN2; MFAP2; FOXL2; EFEMP1;	GO:0048048~embryonic eye morphogenesis	4	9	44.4444444444444	0.0116022080632401	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	SIX1; NET1; SMO; SIX4;	GO:0051451~myoblast migration	4	9	44.4444444444444	0.0116022080632401	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	PXDN; LAMB2; LAMB3; LAMB1;	GO:0070831~basement membrane assembly	4	9	44.4444444444444	0.0116022080632401	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
down	RNASE2; RNASE3; RNASE6;	GO:0006401~RNA catabolic process	3	25	12	0.0118334231229873	0.0782709924668993	1	1	0.846953560947197	0.99546503601856	0.672248937904653
down	PYURF; TMEM246; CWH43;	GO:0006506~GPI anchor biosynthetic process	3	25	12	0.0118334231229873	0.0782709924668993	1	1	0.846953560947197	0.99546503601856	0.672248937904653
down	CHMP1B; CHMP4C; CHMP1A;	GO:0006997~nucleus organization	3	25	12	0.0118334231229873	0.0782709924668993	1	1	0.846953560947197	0.99546503601856	0.672248937904653
down	ARPC2; OCLN; BRK1;	GO:0010592~positive regulation of lamellipodium assembly	3	25	12	0.0118334231229873	0.0782709924668993	1	1	0.846953560947197	0.99546503601856	0.672248937904653
down	CRABP2; ALDH1A3; ADH7;	GO:0042573~retinoic acid metabolic process	3	25	12	0.0118334231229873	0.0782709924668993	1	1	0.846953560947197	0.99546503601856	0.672248937904653
up	TNFRSF10B; ADGRB2; TRPA1; F2; IFNG; IL2RA; CD4; GP1BA; INHBA; CD3G; CCL2; EDNRB; LAMA1; BSG; LIFR; GLP1R; CCR5; CD80; TRBV7-1; TRBV17; TRBV25-1; TRBV7-6; TRBV29-1; TRBV7-7; TRBV14; TRBV5-7; TRBV30; TRBV6-7; TRBV7-4; TRBV6-5; TRBV16; TRBV23-1; PDCD1LG2;	GO:0007166~cell surface receptor signaling pathway	33	268	12.3134328358209	0.011955919961373	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
down	CKB; FCGR2B; HAP1; FOXC1;	GO:0021549~cerebellum development	4	48	8.33333333333333	0.0119632372259456	0.0782709924668993	1	1	0.849346085130663	0.99546503601856	0.672248937904653
down	EGFR; CCNB1; AQP1; BTC;	GO:0048146~positive regulation of fibroblast proliferation	4	48	8.33333333333333	0.0119632372259456	0.0782709924668993	1	1	0.849346085130663	0.99546503601856	0.672248937904653
down	LYPLA2; NCAM1; EPHB3; GRB7; SIAH1; TNR; EFNA3; EFNA5; UNC5B;	GO:0007411~axon guidance	9	206	4.36893203883495	0.0121749916823244	0.0794536794852988	1	1	0.851821110148042	0.99546503601856	0.682406725188734
up	GLI3; NLGN4Y; SHANK3; NRXN2; SHANK2;	GO:0071625~vocalization behavior	5	15	33.3333333333333	0.0123486294317739	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
down	ORM1; GSTP1; BPI; GPNMB;	GO:0032720~negative regulation of tumor necrosis factor production	4	49	8.16326530612245	0.0127688304629699	0.083149079580679	1	1	0.857036341434663	0.99546503601856	0.714145543248346
up	SEMA7A; FN1; L1CAM; MAP1B; TNFRSF12A; TRPC5; DBN1; CTTN;	GO:0045773~positive regulation of axon extension	8	36	22.2222222222222	0.0128091591784023	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
down	BOP1; RRS1; MRPL11;	GO:0000027~ribosomal large subunit assembly	3	26	11.5384615384615	0.013033973281804	0.084329247735277	1	1	0.860242236599064	0.99546503601856	0.724281696674698
down	GSTP1; CD9; OLIG1;	GO:0014003~oligodendrocyte development	3	26	11.5384615384615	0.013033973281804	0.084329247735277	1	1	0.860242236599064	0.99546503601856	0.724281696674698
down	TACSTD2; TJP1; CGNL1;	GO:0051497~negative regulation of stress fiber assembly	3	26	11.5384615384615	0.013033973281804	0.084329247735277	1	1	0.860242236599064	0.99546503601856	0.724281696674698
up	WNT9A; PCGF2; SIX1; MEGF8; MDFI; ALX4; SATB2; HOXC4; HOXC9;	GO:0048704~embryonic skeletal system morphogenesis	9	44	20.4545454545455	0.0132706065791148	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
down	GIPC1; GRIN2D; HRH2; PLK2;	GO:0048167~regulation of synaptic plasticity	4	50	8	0.0136082215636767	0.087856077118812	1	1	0.868670318920202	0.99546503601856	0.754572705291397
up	TBX3; ITGA2; SOX9; FASN; NRG1; CAV1;	GO:0030879~mammary gland development	6	22	27.2727272727273	0.0136356316072985	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	ITGAV; ITGA2; ITGB6; COL16A1; ITGB4; ITGB5;	GO:0033627~cell adhesion mediated by integrin	6	22	27.2727272727273	0.0136356316072985	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
down	SPINT1; SPINT2; RARG; SDC4; GRHL3;	GO:0001843~neural tube closure	5	78	6.41025641025641	0.0139786897030754	0.0887455293848618	1	1	0.871863959798585	0.99546503601856	0.762211976524883
down	FCN1; EMP2; ANGPT1;	GO:0034394~protein localization to cell surface	3	27	11.1111111111111	0.0143014879323289	0.0887455293848618	1	1	0.875185346312103	0.99546503601856	0.762211976524883
down	TJP1; WWC1; AMOTL2;	GO:0035329~hippo signaling	3	27	11.1111111111111	0.0143014879323289	0.0887455293848618	1	1	0.875185346312103	0.99546503601856	0.762211976524883
down	MAPK13; AQP1; NSMCE3; RUVBL2;	GO:0034644~cellular response to UV	4	51	7.84313725490196	0.01448185753146	0.0887455293848618	1	1	0.878642299622092	0.99546503601856	0.762211976524883
down	LTF; ADRB2; TCL1A; HIGD1A;	GO:0071902~positive regulation of protein serine/threonine kinase activity	4	51	7.84313725490196	0.01448185753146	0.0887455293848618	1	1	0.878642299622092	0.99546503601856	0.762211976524883
down	FGFR3; POLR2L; FGFBP1; ESRP1; ESRP2;	GO:0008543~fibroblast growth factor receptor signaling pathway	5	79	6.32911392405063	0.0146602324084475	0.089656390895475	1	1	0.87961394450685	0.99546503601856	0.770035126120782
up	PLXNB1; MDK; TNC; ARHGDIA; CDH13; PLXNB3; PLXNA2; PLXNB2; PLXNA1;	GO:0007162~negative regulation of cell adhesion	9	45	20	0.0149272263974723	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	ITGA3; PCSK6; FSTL3; FSTL1;	GO:0030510~regulation of BMP signaling pathway	4	10	40	0.015324351349999	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	LRP4; NLGN2; NRXN2; NLGN4Y;	GO:0097104~postsynaptic membrane assembly	4	10	40	0.015324351349999	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
down	KCNK1; SCNN1A; SCNN1B; SLC28A3; SLC12A1;	GO:0035725~sodium ion transmembrane transport	5	80	6.25	0.0153636746499635	0.0935510962265534	1	1	0.887684983313359	0.99546503601856	0.803485724353279
down	ANXA9; ANXA3; PLN; CCAR2;	GO:0043086~negative regulation of catalytic activity	4	52	7.69230769230769	0.0153901637573368	0.0935510962265534	1	1	0.887684983313359	0.99546503601856	0.803485724353279
down	SULT1E1; ZBTB16; KLF5; CDS1;	GO:0045600~positive regulation of fat cell differentiation	4	52	7.69230769230769	0.0153901637573368	0.0935510962265534	1	1	0.887684983313359	0.99546503601856	0.803485724353279
down	ATP13A5; ATP13A4; TMEM63C;	GO:0006812~cation transport	3	28	10.7142857142857	0.0156364057618801	0.093911879227228	1	1	0.889827671204115	0.99546503601856	0.806584394516687
down	CLDN4; CFL1; EFNA5;	GO:0022604~regulation of cell morphogenesis	3	28	10.7142857142857	0.0156364057618801	0.093911879227228	1	1	0.889827671204115	0.99546503601856	0.806584394516687
down	KRT17; TMEM79; FOXQ1;	GO:0031069~hair follicle morphogenesis	3	28	10.7142857142857	0.0156364057618801	0.093911879227228	1	1	0.889827671204115	0.99546503601856	0.806584394516687
down	RARG; PITX1; ZBTB16;	GO:0035116~embryonic hindlimb morphogenesis	3	28	10.7142857142857	0.0156364057618801	0.093911879227228	1	1	0.889827671204115	0.99546503601856	0.806584394516687
down	FOXN1; SPNS2; SIT1;	GO:0043029~T cell homeostasis	3	28	10.7142857142857	0.0156364057618801	0.093911879227228	1	1	0.889827671204115	0.99546503601856	0.806584394516687
down	TGFA; BTC; EPGN;	GO:0045840~positive regulation of mitotic nuclear division	3	28	10.7142857142857	0.0156364057618801	0.093911879227228	1	1	0.889827671204115	0.99546503601856	0.806584394516687
down	MAPK13; LCN2; OTUB1; XCL1; CCL26;	GO:0071347~cellular response to interleukin-1	5	81	6.17283950617284	0.0160892930726709	0.0964397984375802	1	1	0.892057815743474	0.99546503601856	0.828296026766485
up	TBX1; LRP5; PDGFA; WNT5A; SOX9; SMO;	GO:0002053~positive regulation of mesenchymal cell proliferation	6	23	26.0869565217391	0.0161619570159798	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	PLAU; PDGFA; PLXNA1;	GO:0014910~regulation of smooth muscle cell migration	3	5	60	0.0161715459053597	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	CNR1; MILR1; CD84;	GO:0033004~negative regulation of mast cell activation	3	5	60	0.0161715459053597	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	ADCY6; SLC4A1; AVPR2;	GO:0035811~negative regulation of urine volume	3	5	60	0.0161715459053597	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	HMGB3; INHBA; SFRP1;	GO:0045578~negative regulation of B cell differentiation	3	5	60	0.0161715459053597	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	GNA11; SLC45A2; DCT;	GO:0048066~developmental pigmentation	3	5	60	0.0161715459053597	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	NRP1; SEMA3C; PLXNA1;	GO:0060666~dichotomous subdivision of terminal units involved in salivary gland branching	3	5	60	0.0161715459053597	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	NRP1; SIX1; SIX4;	GO:0061551~trigeminal ganglion development	3	5	60	0.0161715459053597	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
down	UCHL1; GJB2; EIF4EBP1; STUB1;	GO:0002931~response to ischemia	4	53	7.54716981132075	0.0163335439765118	0.0970739190425982	1	1	0.894380882971972	0.99546503601856	0.833742321617123
down	GCNT3; GALNT18; B3GNT3; B3GNT8;	GO:0006493~protein O-linked glycosylation	4	53	7.54716981132075	0.0163335439765118	0.0970739190425982	1	1	0.894380882971972	0.99546503601856	0.833742321617123
down	MAPK13; MMP8; SPON2; IL36A;	GO:0032755~positive regulation of interleukin-6 production	4	53	7.54716981132075	0.0163335439765118	0.0970739190425982	1	1	0.894380882971972	0.99546503601856	0.833742321617123
down	ADGRG6; KLK6; MAL2; MALL;	GO:0042552~myelination	4	53	7.54716981132075	0.0163335439765118	0.0970739190425982	1	1	0.894380882971972	0.99546503601856	0.833742321617123
down	TGM5; UBL4A; CPE; TGM1; UBE2M;	GO:0006464~cellular protein modification process	5	82	6.09756097560976	0.0168373570228693	0.0970739190425982	1	1	0.896802804125088	0.99546503601856	0.833742321617123
down	XCL1; CD1C; CD1A;	GO:0001916~positive regulation of T cell mediated cytotoxicity	3	29	10.3448275862069	0.0170390787379571	0.0970739190425982	1	1	0.899330026197904	0.99546503601856	0.833742321617123
down	FGFR3; FOXC1; COL13A1;	GO:0001958~endochondral ossification	3	29	10.3448275862069	0.0170390787379571	0.0970739190425982	1	1	0.899330026197904	0.99546503601856	0.833742321617123
down	GIPC1; CDKN2B; NPNT;	GO:0030511~positive regulation of transforming growth factor beta receptor signaling pathway	3	29	10.3448275862069	0.0170390787379571	0.0970739190425982	1	1	0.899330026197904	0.99546503601856	0.833742321617123
down	XCL1; IL20RB; PGLYRP3;	GO:0032689~negative regulation of interferon-gamma production	3	29	10.3448275862069	0.0170390787379571	0.0970739190425982	1	1	0.899330026197904	0.99546503601856	0.833742321617123
down	NUPR1; PHLDA3; TMEM109;	GO:0042771~intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	3	29	10.3448275862069	0.0170390787379571	0.0970739190425982	1	1	0.899330026197904	0.99546503601856	0.833742321617123
down	PTPRZ1; NTRK2; BOK;	GO:0048709~oligodendrocyte differentiation	3	29	10.3448275862069	0.0170390787379571	0.0970739190425982	1	1	0.899330026197904	0.99546503601856	0.833742321617123
down	EGFR; ERBB3; BTC;	GO:2000145~regulation of cell motility	3	29	10.3448275862069	0.0170390787379571	0.0970739190425982	1	1	0.899330026197904	0.99546503601856	0.833742321617123
down	MMP3; TAL1; TCL1A; BRK1;	GO:0031334~positive regulation of protein-containing complex assembly	4	54	7.40740740740741	0.0173123802540054	0.0977468660408731	1	1	0.90024377320828	0.99546503601856	0.839522086132665
down	KLK8; S100B; HRH2; ADGRF1; PLK2;	GO:0007613~memory	5	83	6.02409638554217	0.0176081284235441	0.0992308545738045	1	1	0.901969569251735	0.99546503601856	0.852267672762957
down	PHGDH; MAP2; RAB11A; ADGRF1; NLGN1; GPM6A;	GO:0031175~neuron projection development	6	115	5.21739130434783	0.0179617541285089	0.101034866972862	1	1	0.904729091535284	0.99546503601856	0.867761860085883
down	TAL1; GAS1; ROR2; GATA1;	GO:0045165~cell fate commitment	4	55	7.27272727272727	0.0183270329975083	0.102775274600324	1	1	0.907616963692488	0.99546503601856	0.882709762778911
down	PIR; PRSS3; AKR1C2;	GO:0007586~digestion	3	30	10	0.0185097758235409	0.102775274600324	1	1	0.907616963692488	0.99546503601856	0.882709762778911
down	DAD1; ALG8; OSTC;	GO:0018279~protein N-linked glycosylation via asparagine	3	30	10	0.0185097758235409	0.102775274600324	1	1	0.907616963692488	0.99546503601856	0.882709762778911
down	TXN; MMP8; FOXC1;	GO:0043388~positive regulation of DNA binding	3	30	10	0.0185097758235409	0.102775274600324	1	1	0.907616963692488	0.99546503601856	0.882709762778911
down	GZMA; ID1; CTNNBIP1;	GO:0043392~negative regulation of DNA binding	3	30	10	0.0185097758235409	0.102775274600324	1	1	0.907616963692488	0.99546503601856	0.882709762778911
down	IGFBP3; CTNNBIP1; NDRG2;	GO:0048662~negative regulation of smooth muscle cell proliferation	3	30	10	0.0185097758235409	0.102775274600324	1	1	0.907616963692488	0.99546503601856	0.882709762778911
down	LTF; FGFR3; RARG;	GO:0060349~bone morphogenesis	3	30	10	0.0185097758235409	0.102775274600324	1	1	0.907616963692488	0.99546503601856	0.882709762778911
down	CLDN5; SLC9A3R1; ALOX15B; KRT16; SLURP1; ADAM15;	GO:0030336~negative regulation of cell migration	6	116	5.17241379310345	0.0186268758815282	0.10323535070369	1	1	0.910642353571463	0.99546503601856	0.886661235247776
up	PDLIM1; ARHGEF11; FLNB; PDGFA; CORO1A; PFN2; RAC3; FGD1; DMTN; FSCN1; INF2; PALLD; ARHGEF17; DLC1; MICALL2; SHROOM2; SMTN; FHL3; MICAL3; AMOTL1; RHOU;	GO:0030036~actin cytoskeleton organization	21	157	13.3757961783439	0.0190053909546647	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
down	CCNB1; MUC1; SFN; PLK2;	GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest	4	56	7.14285714285714	0.0193778409956906	0.10682506756352	1	1	0.913815323444534	0.99546503601856	0.917492367833956
up	LAMA5; TGFB1I1; VEGFC; JAG2;	GO:0016331~morphogenesis of embryonic epithelium	4	11	36.3636363636364	0.0197183386984441	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
down	LTF; BTNL3; BTNL8;	GO:0001817~regulation of cytokine production	3	31	9.67741935483871	0.0200486865755174	0.10682506756352	1	1	0.919040912720691	0.99546503601856	0.917492367833956
down	EGFR; NTRK2; NMUR1;	GO:0007202~activation of phospholipase C activity	3	31	9.67741935483871	0.0200486865755174	0.10682506756352	1	1	0.919040912720691	0.99546503601856	0.917492367833956
down	GIPC1; S100P; PRSS3;	GO:0043542~endothelial cell migration	3	31	9.67741935483871	0.0200486865755174	0.10682506756352	1	1	0.919040912720691	0.99546503601856	0.917492367833956
down	CD19; FGFR3; TNFAIP8L3;	GO:0043552~positive regulation of phosphatidylinositol 3-kinase activity	3	31	9.67741935483871	0.0200486865755174	0.10682506756352	1	1	0.919040912720691	0.99546503601856	0.917492367833956
down	CCNB1; TAL1; EIF4EBP1;	GO:0045931~positive regulation of mitotic cell cycle	3	31	9.67741935483871	0.0200486865755174	0.10682506756352	1	1	0.919040912720691	0.99546503601856	0.917492367833956
down	CLDN5; DKK1; PAX9;	GO:0060325~face morphogenesis	3	31	9.67741935483871	0.0200486865755174	0.10682506756352	1	1	0.919040912720691	0.99546503601856	0.917492367833956
down	EGFR; ELANE; IL18; NOTCH3;	GO:0048661~positive regulation of smooth muscle cell proliferation	4	57	7.01754385964912	0.0204651214810185	0.10863088250928	1	1	0.920930466645834	0.99546503601856	0.933002036755718
down	PTGES; EGFR; TNNT2; S100A16;	GO:0051592~response to calcium ion	4	57	7.01754385964912	0.0204651214810185	0.10863088250928	1	1	0.920930466645834	0.99546503601856	0.933002036755718
up	MAP1B; TRIM46; MARK4; GAS2L1; NCKAP5L; MTCL1; NAV1;	GO:0001578~microtubule bundle formation	7	32	21.875	0.0206887030237448	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	TBX1; TFAP2A; MMP14; MMP16; SIX1; NODAL; SIX4;	GO:0048701~embryonic cranial skeleton morphogenesis	7	32	21.875	0.0206887030237448	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	SNAI2; WNT5A; NOTCH1; SOX9; HMGA2; TGFB2; CUL7; LOXL2;	GO:0001837~epithelial to mesenchymal transition	8	40	20	0.0211269175919401	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
down	GSTP1; CFL1; PEMT;	GO:0043200~response to amino acid	3	32	9.375	0.0216559246303019	0.114147924406224	1	1	0.92518834357501	0.99546503601856	0.980386456432838
down	GZMA; CTSW; CTSV;	GO:0051603~proteolysis involved in cellular protein catabolic process	3	32	9.375	0.0216559246303019	0.114147924406224	1	1	0.92518834357501	0.99546503601856	0.980386456432838
down	CDK2AP2; EFNA5; RASSF1;	GO:0070507~regulation of microtubule cytoskeleton organization	3	32	9.375	0.0216559246303019	0.114147924406224	1	1	0.92518834357501	0.99546503601856	0.980386456432838
up	AGRN; SDC3; GPC4; SDC1; GPC1; HSPG2;	GO:0006027~glycosaminoglycan catabolic process	6	25	24	0.0221450298187443	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
down	FUT3; KIF14; RHOD; RND3; AMOTL2;	GO:0030334~regulation of cell migration	5	89	5.61797752808989	0.0227233166657531	0.119026338753038	1	1	0.929840453410711	0.99546503601856	1
down	UCHL1; KCNQ1; PPP1R14A; SLAMF8;	GO:0035690~cellular response to drug	4	59	6.77966101694915	0.022750261606254	0.119026338753038	1	1	0.929840453410711	0.99546503601856	1
up	SERPINE1; SERPINE2; CTSZ;	GO:0010757~negative regulation of plasminogen activation	3	6	50	0.0229647145788932	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	NEFL; TNC; MAP1B;	GO:0014012~peripheral nervous system axon regeneration	3	6	50	0.0229647145788932	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	CCL2; MMP14; SCRIB;	GO:0043615~astrocyte cell migration	3	6	50	0.0229647145788932	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	LRP5; COL4A1; LAMA1;	GO:0061304~retinal blood vessel morphogenesis	3	6	50	0.0229647145788932	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	SH3PXD2A; CD109; SBNO2;	GO:0072675~osteoclast fusion	3	6	50	0.0229647145788932	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	SERPINE1; FAM20C; HTRA1;	GO:0097187~dentinogenesis	3	6	50	0.0229647145788932	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	NRP1; FN1; SEMA3F;	GO:1901166~neural crest cell migration involved in autonomic nervous system development	3	6	50	0.0229647145788932	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
down	TK1; FPGS; GDA;	GO:0006139~nucleobase-containing compound metabolic process	3	33	9.09090909090909	0.0233315310789538	0.119026338753038	1	1	0.932360346238382	0.99546503601856	1
down	CSNK2B; FABP5; PEMT;	GO:0006656~phosphatidylcholine biosynthetic process	3	33	9.09090909090909	0.0233315310789538	0.119026338753038	1	1	0.932360346238382	0.99546503601856	1
down	PLN; TNNT2; KCNQ1;	GO:0008016~regulation of heart contraction	3	33	9.09090909090909	0.0233315310789538	0.119026338753038	1	1	0.932360346238382	0.99546503601856	1
down	RHOD; ABLIM3; ARHGEF4;	GO:0030032~lamellipodium assembly	3	33	9.09090909090909	0.0233315310789538	0.119026338753038	1	1	0.932360346238382	0.99546503601856	1
down	SAA1; CCL26; XCL1;	GO:0048247~lymphocyte chemotaxis	3	33	9.09090909090909	0.0233315310789538	0.119026338753038	1	1	0.932360346238382	0.99546503601856	1
down	ERBB3; LCN2; BOK;	GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand	3	33	9.09090909090909	0.0233315310789538	0.119026338753038	1	1	0.932360346238382	0.99546503601856	1
up	ABRA; LPAR1; GPR55; ROBO1; NET1; GPR174; P2RY10;	GO:0035025~positive regulation of Rho protein signal transduction	7	33	21.2121212121212	0.0235531911114417	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	WNT9A; TBX3; TFAP2A; WNT3; ALX4; TP63; ZNF358;	GO:0035115~embryonic forelimb morphogenesis	7	33	21.2121212121212	0.0235531911114417	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
down	HAP1; VAMP2; SYTL1; RAB25; RAB11A;	GO:0006887~exocytosis	5	90	5.55555555555556	0.023659727036847	0.120496751716375	1	1	0.932360346238382	0.99546503601856	1
up	LRP5; ITGAV; SOX8; TMEM119;	GO:0033690~positive regulation of osteoblast proliferation	4	12	33.3333333333333	0.0248128046011518	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	PLXNB1; WNT5A; NLGN2; FGF13;	GO:1904862~inhibitory synapse assembly	4	12	33.3333333333333	0.0248128046011518	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	TERT; TBX3; HMGA2; SIRT6;	GO:2000648~positive regulation of stem cell proliferation	4	12	33.3333333333333	0.0248128046011518	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
down	EGFR; MPV17; ROMO1;	GO:0034614~cellular response to reactive oxygen species	3	34	8.82352941176471	0.0250754777350373	0.121382359882123	1	1	0.937844818863314	0.99546503601856	1
down	MST1R; TARBP2; SLC22A16; FETUB;	GO:0007338~single fertilization	4	61	6.55737704918033	0.0251845639379491	0.121382359882123	1	1	0.937844818863314	0.99546503601856	1
up	SIX1; NR2F2; EGFL7; SIX4; IGF1R; SPOCK1; SPARC; SIX5; TFAP2A;	GO:0048856~anatomical structure development	9	50	18	0.025554209432603	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
down	NR2F6; RARG; CCNB1; TBP; POLR2L; NOTCH3; MED31;	GO:0006367~transcription initiation from RNA polymerase II promoter	7	161	4.34782608695652	0.0259521661707469	0.121382359882123	1	1	0.940836349386004	0.99546503601856	1
up	WTIP; PDLIM1; PLOD2; APAF1; ACTN4; PLAU; PKM; ITGA2; ALAS2; EDNRA; MMP14; TGFB2; CAV1; KCNMA1; CYGB; AJUBA; ANGPTL4; LOXL2; PGF; MMP2; VEGFC;	GO:0001666~response to hypoxia	21	163	12.8834355828221	0.0263689914240821	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
down	KLK8; HHEX; KLK6; TMPRSS4;	GO:0009611~response to wounding	4	62	6.45161290322581	0.0264582181348516	0.121382359882123	1	1	0.944014850566362	0.99546503601856	1
down	CREG1; IGFBP2; NSMCE3; RUVBL2;	GO:0040008~regulation of growth	4	62	6.45161290322581	0.0264582181348516	0.121382359882123	1	1	0.944014850566362	0.99546503601856	1
down	EFNA5; EPHB3; NTRK2; NLGN1;	GO:0051965~positive regulation of synapse assembly	4	62	6.45161290322581	0.0264582181348516	0.121382359882123	1	1	0.944014850566362	0.99546503601856	1
up	ITGAV; ITGA2; CORO1A; GAS6; FAT2;	GO:0031589~cell-substrate adhesion	5	19	26.3157894736842	0.0266159032280113	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
down	KRT1; ELANE; SAA1; CXCL17; NLRX1;	GO:0050728~negative regulation of inflammatory response	5	93	5.37634408602151	0.0266168487692524	0.121382359882123	1	1	0.944014850566362	0.99546503601856	1
up	TBX3; SLIT3; NOTCH1; TGFB2; SOX4; HES1; ROBO1;	GO:0060412~ventricular septum morphogenesis	7	34	20.5882352941176	0.0266790290523903	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
down	KLK8; EMP1; EMP2;	GO:0008219~cell death	3	35	8.57142857142857	0.0268876702989225	0.121382359882123	1	1	0.944014850566362	0.99546503601856	1
down	MAP2; CFL1; WWC1;	GO:0030010~establishment of cell polarity	3	35	8.57142857142857	0.0268876702989225	0.121382359882123	1	1	0.944014850566362	0.99546503601856	1
down	EGFR; SERPINB12; MAD2L2;	GO:0042177~negative regulation of protein catabolic process	3	35	8.57142857142857	0.0268876702989225	0.121382359882123	1	1	0.944014850566362	0.99546503601856	1
down	NUPR1; TGM1; PTK6;	GO:0045787~positive regulation of cell cycle	3	35	8.57142857142857	0.0268876702989225	0.121382359882123	1	1	0.944014850566362	0.99546503601856	1
down	LILRA5; ORM1; LILRA2;	GO:0050718~positive regulation of interleukin-1 beta secretion	3	35	8.57142857142857	0.0268876702989225	0.121382359882123	1	1	0.944014850566362	0.99546503601856	1
down	PF4; GATA1; UNC5B;	GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand	3	35	8.57142857142857	0.0268876702989225	0.121382359882123	1	1	0.944014850566362	0.99546503601856	1
down	OVOL1; UPK3A; CA2; ASS1; FOXC1;	GO:0001822~kidney development	5	94	5.31914893617021	0.0276524606444093	0.121382359882123	1	1	0.947398416339001	0.99546503601856	1
down	AKR1B10; LRAT; SDC4; ADH7;	GO:0001523~retinoid metabolic process	4	63	6.34920634920635	0.0277698018426369	0.121382359882123	1	1	0.947398416339001	0.99546503601856	1
down	ASS1; IGFBP2; ALDH3A1; DAD1;	GO:0007584~response to nutrient	4	63	6.34920634920635	0.0277698018426369	0.121382359882123	1	1	0.947398416339001	0.99546503601856	1
up	DVL1; TBX1; NLGN4Y; PTCHD1; CIC; GAD1; SHANK3; NRXN2; SHANK2;	GO:0035176~social behavior	9	51	17.6470588235294	0.0281939047281248	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
down	PSMC3; PSMB6; KIF14; FBXW5; NCCRP1;	GO:0031146~SCF-dependent proteasomal ubiquitin-dependent protein catabolic process	5	95	5.26315789473684	0.0287133078847664	0.121382359882123	1	1	0.95100755316315	0.99546503601856	1
up	APOA2; PKM; AXL; NOTCH1; PGF; BAAT; GAS6; PTPRU;	GO:0031100~animal organ regeneration	8	43	18.6046511627907	0.0294654778258721	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
down	CLDN1; ASS1; GBP6; XCL1; CCL26;	GO:0071346~cellular response to interferon-gamma	5	96	5.20833333333333	0.0297995477451809	0.121382359882123	1	1	0.953191962917695	0.99546503601856	1
up	IFNG; ITGA2; ITGA3; SOX9; CCR6; TGFB2; DOCK1;	GO:0010634~positive regulation of epithelial cell migration	7	35	20	0.0300754390825113	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
down	ADORA1; FASTK; UACA; IFI27;	GO:0097190~apoptotic signaling pathway	4	65	6.15384615384615	0.0305074170750732	0.121382359882123	1	1	0.953191962917695	0.99546503601856	1
up	FN1; APP; MAPK12; CAV1;	GO:0010952~positive regulation of peptidase activity	4	13	30.7692307692308	0.0306285396868773	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	APOA2; BMP1; PRKACA; ZDHHC8;	GO:0034380~high-density lipoprotein particle assembly	4	13	30.7692307692308	0.0306285396868773	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	NOTCH1; DLX1; HES1; TMEM98;	GO:0048715~negative regulation of oligodendrocyte differentiation	4	13	30.7692307692308	0.0306285396868773	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	ADAMTS3; SNCA; LTBP2; B4GALT7;	GO:0097435~supramolecular fiber organization	4	13	30.7692307692308	0.0306285396868773	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	ACTN4; FHL3; PTPN14; TCERG1L;	GO:1903506~regulation of nucleic acid-templated transcription	4	13	30.7692307692308	0.0306285396868773	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
down	RAMP2; HSPB1; ANXA3; JUP; AQP1; ECM1;	GO:0045766~positive regulation of angiogenesis	6	131	4.58015267175572	0.0306889295256766	0.121382359882123	1	1	0.953191962917695	0.99546503601856	1
down	LILRA5; NLRP10; LILRA2;	GO:2000778~positive regulation of interleukin-6 secretion	3	37	8.10810810810811	0.0307161036571473	0.121382359882123	1	1	0.953191962917695	0.99546503601856	1
down	GABRP; CLDN4; CLIC3; SLC12A1; GABRE;	GO:1902476~chloride transmembrane transport	5	97	5.15463917525773	0.0309113290590977	0.121382359882123	1	1	0.954184871212401	0.99546503601856	1
up	ITGA2; VEGFC; CSPG4;	GO:0006929~substrate-dependent cell migration	3	7	42.8571428571429	0.0310657897583293	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	CD4; CCR5; GAS6;	GO:0019064~fusion of virus membrane with host plasma membrane	3	7	42.8571428571429	0.0310657897583293	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	TGFB2; SIX1; SIX4;	GO:0048699~generation of neurons	3	7	42.8571428571429	0.0310657897583293	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	SLIT3; PADI2; ROBO1;	GO:0070100~negative regulation of chemokine-mediated signaling pathway	3	7	42.8571428571429	0.0310657897583293	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	EDNRB; EDNRA; BCAR1;	GO:0086100~endothelin receptor signaling pathway	3	7	42.8571428571429	0.0310657897583293	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	PDGFA; RAC3; NCKAP1L; PARVA; RHOU;	GO:0030031~cell projection assembly	5	20	25	0.031339482048234	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
down	MACROD2; MNDA; BATF; CCAR2; OTUB1; UBE2E2; SIRT7; ZNF652; POLE3;	GO:0006974~cellular response to DNA damage stimulus	9	245	3.6734693877551	0.0316043405253408	0.121382359882123	1	1	0.954184871212401	0.99546503601856	1
down	PTPRZ1; RRS1; SERPINB12; PLD4;	GO:0002244~hematopoietic progenitor cell differentiation	4	66	6.06060606060606	0.0319337276735587	0.121382359882123	1	1	0.955246255941225	0.99546503601856	1
down	HAUS5; CCNB1; CDKN2B; DYNLL1; TUBB4B; TPD52L1;	GO:0000086~G2/M transition of mitotic cell cycle	6	133	4.51127819548872	0.0326074686636995	0.121382359882123	1	1	0.955246255941225	0.99546503601856	1
down	FASTK; ESRP1; ESRP2;	GO:0043484~regulation of RNA splicing	3	38	7.89473684210526	0.0327318523539755	0.121382359882123	1	1	0.955246255941225	0.99546503601856	1
down	DUSP14; PTPRZ1; PTPN3; DUSP2; TIMM50;	GO:0035335~peptidyl-tyrosine dephosphorylation	5	99	5.05050505050505	0.0332120691653355	0.121382359882123	1	1	0.956383453864964	0.99546503601856	1
down	PLN; EIF6; GGH; RETN;	GO:0032868~response to insulin	4	67	5.97014925373134	0.0333985264024672	0.121382359882123	1	1	0.956383453864964	0.99546503601856	1
down	MAPK13; AQP1; LCN2; ANXA1;	GO:0070301~cellular response to hydrogen peroxide	4	67	5.97014925373134	0.0333985264024672	0.121382359882123	1	1	0.956383453864964	0.99546503601856	1
up	NRP1; TBX1; TGFB2; SEMA3C; PARVA; ROBO1;	GO:0003148~outflow tract septum morphogenesis	6	28	21.4285714285714	0.0336505966257854	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	SNAI2; SLIT3; NOTCH1; SOX9; JAG1; ROBO1;	GO:0003180~aortic valve morphogenesis	6	28	21.4285714285714	0.0336505966257854	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	WNT9A; NDST1; EVC; ARMC9; SFRP1; RAB34; SMO;	GO:0045880~positive regulation of smoothened signaling pathway	7	36	19.4444444444444	0.0337508358507241	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	CD3G; FAT1; PARVA; CDC42BPB; CAP2; RHOB; RAC3; RHOU; FSCN1;	GO:0007163~establishment or maintenance of cell polarity	9	53	16.9811320754717	0.0340351296839375	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
down	IGFBP3; ERBB3; PTK6;	GO:0009968~negative regulation of signal transduction	3	39	7.69230769230769	0.0348148684052132	0.124515810488396	1	1	0.957604888671944	0.99546503601856	1
down	EGFR; MT1G; MT1X;	GO:0071276~cellular response to cadmium ion	3	39	7.69230769230769	0.0348148684052132	0.124515810488396	1	1	0.957604888671944	0.99546503601856	1
down	KCNK1; KCNA5; AQP1; KCNG1;	GO:0006813~potassium ion transport	4	68	5.88235294117647	0.0349019033135289	0.124531643183775	1	1	0.957604888671944	0.99546503601856	1
down	GATA1; TAL1; PSMC3; PSMB6;	GO:1902036~regulation of hematopoietic stem cell differentiation	4	68	5.88235294117647	0.0349019033135289	0.124531643183775	1	1	0.957604888671944	0.99546503601856	1
up	ARVCF; CDH13; AJUBA; PCDHGC3; PCDHB2; CDH2; CDH11; CDH3;	GO:0016339~calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules	8	45	17.7777777777778	0.0361372825469822	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	ACTN4; DMTN; SHROOM2; DPYSL3; FSCN1; LIMA1; RHOB; ESPN;	GO:0051017~actin filament bundle assembly	8	45	17.7777777777778	0.0361372825469822	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
down	IGFBP3; KIF14; OGFR; MAD2L2;	GO:0001558~regulation of cell growth	4	69	5.79710144927536	0.0364439291318313	0.129336935593478	1	1	0.958920280002537	0.99546503601856	1
down	KIF14; NTRK2; GNG12; TACC2;	GO:0021987~cerebral cortex development	4	69	5.79710144927536	0.0364439291318313	0.129336935593478	1	1	0.958920280002537	0.99546503601856	1
down	AQP1; PTK6; TESC; RARG;	GO:0071300~cellular response to retinoic acid	4	69	5.79710144927536	0.0364439291318313	0.129336935593478	1	1	0.958920280002537	0.99546503601856	1
up	SNAI2; EDNRA; SOX9; NRG1; SOX8;	GO:0014032~neural crest cell development	5	21	23.8095238095238	0.0365553152989714	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
down	ENDOU; CLEC10A; NECAP1; TMPRSS13; TMPRSS4; DENND1C; RHOV;	GO:0006897~endocytosis	7	174	4.02298850574713	0.0366766895793538	0.129336935593478	1	1	0.958920280002537	0.99546503601856	1
down	KRT1; DHCR24; DUOX2; DUOX1; PRDX1;	GO:0006979~response to oxidative stress	5	102	4.90196078431373	0.0368579751831359	0.129336935593478	1	1	0.958920280002537	0.99546503601856	1
down	GM2A; CPTP; GLTP;	GO:0006687~glycosphingolipid metabolic process	3	40	7.5	0.0369647709441234	0.129336935593478	1	1	0.960340902639578	0.99546503601856	1
down	ERBB3; SIAH1; BOK;	GO:0051402~neuron apoptotic process	3	40	7.5	0.0369647709441234	0.129336935593478	1	1	0.960340902639578	0.99546503601856	1
up	SNAI2; EFNB2; PTPRK; CD109;	GO:0010839~negative regulation of keratinocyte proliferation	4	14	28.5714285714286	0.037178735867379	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	EXTL3; EXT1; XYLT2; VANGL2;	GO:0015012~heparan sulfate proteoglycan biosynthetic process	4	14	28.5714285714286	0.037178735867379	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	TBX1; JAG1; NPRL3; SIX1;	GO:0035909~aorta morphogenesis	4	14	28.5714285714286	0.037178735867379	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	SOX15; NR2F2; E2F7; MDFI;	GO:0060707~trophoblast giant cell differentiation	4	14	28.5714285714286	0.037178735867379	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	HMGA2; KAT2A; NODAL; SMO;	GO:2000036~regulation of stem cell population maintenance	4	14	28.5714285714286	0.037178735867379	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	FXYD1; SLC4A1; GLRA1; ANO4; SLC26A7; TTYH3; SLC26A1;	GO:0006821~chloride transport	7	37	18.9189189189189	0.0377127746805789	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
down	NUPR1; HSPB1; TRIB3; BOK;	GO:0010506~regulation of autophagy	4	70	5.71428571428571	0.0380246555316879	0.132078728603732	1	1	0.960340902639578	0.99546503601856	1
up	NCS1; FRMD7; ZNF804A; SFRP1; MARK1; FBXO7;	GO:0010975~regulation of neuron projection development	6	29	20.6896551724138	0.0382055332439075	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
down	PLN; BOK; CALB2;	GO:0051480~regulation of cytosolic calcium ion concentration	3	41	7.31707317073171	0.0391811299371378	0.135939133211128	1	1	0.961879910496372	0.99546503601856	1
down	FOXRED2; RNF5; STUB1; NCCRP1;	GO:0030433~ubiquitin-dependent ERAD pathway	4	71	5.63380281690141	0.0396441154244611	0.137229630315442	1	1	0.961879910496372	0.99546503601856	1
down	EFNA5; EPHB3; NTRK2; PROM2;	GO:0043087~regulation of GTPase activity	4	71	5.63380281690141	0.0396441154244611	0.137229630315442	1	1	0.961879910496372	0.99546503601856	1
up	PALM3; CAV1; PXDN;	GO:0001960~negative regulation of cytokine-mediated signaling pathway	3	8	37.5	0.040458219414035	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	PDLIM1; SLC9A1; NCKAP1L;	GO:0030011~maintenance of cell polarity	3	8	37.5	0.040458219414035	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	MMP14; CSPG4; MMP2;	GO:0048771~tissue remodeling	3	8	37.5	0.040458219414035	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	TERT; NOTCH1; HES1;	GO:0060253~negative regulation of glial cell proliferation	3	8	37.5	0.040458219414035	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	MMP2; FBN2; SFRP1;	GO:0060346~bone trabecula formation	3	8	37.5	0.040458219414035	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	DVL1; LRP4; ETV5;	GO:0071340~skeletal muscle acetylcholine-gated channel clustering	3	8	37.5	0.040458219414035	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	MELTF; FSCN1; PDPN;	GO:0090091~positive regulation of extracellular matrix disassembly	3	8	37.5	0.040458219414035	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	SH3PXD2B; TGFB2; TP63;	GO:1904888~cranial skeletal system development	3	8	37.5	0.040458219414035	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
down	KCNA5; TMEM120A; PRMT8; KCNG1; KCTD3;	GO:0051260~protein homooligomerization	5	105	4.76190476190476	0.0407401431138021	0.138776528902931	1	1	0.963552745123322	0.99546503601856	1
down	RAB38; RAB25; RAB11A; RAB27B;	GO:0032482~Rab protein signal transduction	4	72	5.55555555555556	0.0413023232512029	0.138776528902931	1	1	0.963552745123322	0.99546503601856	1
down	CRYAB; AQP1; SFN; DHCR24;	GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process	4	72	5.55555555555556	0.0413023232512029	0.138776528902931	1	1	0.963552745123322	0.99546503601856	1
up	FLRT2; TBX1; LEFTY1; EPHB4; TGFB2; FAT4; DLC1;	GO:0003007~heart morphogenesis	7	38	18.4210526315789	0.041967907609391	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
down	PLD1; DHCR24; RASSF1; PLK2;	GO:0007265~Ras protein signal transduction	4	73	5.47945205479452	0.0429992752892427	0.138776528902931	1	1	0.96537765562545	0.99546503601856	1
up	NRP1; PDGFB; PDGFA; BCAR1; CSPG4; PDGFC;	GO:0048008~platelet-derived growth factor receptor signaling pathway	6	30	20	0.0431345797955263	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	ESPN; AGRN; NRP1; DPYSL3; FSCN1; TENM2;	GO:0051491~positive regulation of filopodium assembly	6	30	20	0.0431345797955263	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
down	GSTP1; ANXA3; FPGS;	GO:0031100~animal organ regeneration	3	43	6.97674418604651	0.0438112662902537	0.138776528902931	1	1	0.96537765562545	0.99546503601856	1
down	BANF1; LTF; SLPI;	GO:0045071~negative regulation of viral genome replication	3	43	6.97674418604651	0.0438112662902537	0.138776528902931	1	1	0.96537765562545	0.99546503601856	1
up	NOTCH1; TGFB2; JAG1; ROBO1;	GO:0003184~pulmonary valve morphogenesis	4	15	26.6666666666667	0.0444693454200363	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	NCKAP1L; RAC3; TGFB2; FERMT1;	GO:0033630~positive regulation of cell adhesion mediated by integrin	4	15	26.6666666666667	0.0444693454200363	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	IFNG; IL2RA; CTLA4; KAT2A;	GO:0045589~regulation of regulatory T cell differentiation	4	15	26.6666666666667	0.0444693454200363	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	EDNRB; HES1; SIX1; SIX4;	GO:0050678~regulation of epithelial cell proliferation	4	15	26.6666666666667	0.0444693454200363	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
down	HAP1; DHCR24; DUOXA1; DUOXA2;	GO:0008104~protein localization	4	74	5.40540540540541	0.0447349499606311	0.138776528902931	1	1	0.96737636712778	0.99546503601856	1
down	CPE; NMU; NMUR1; PROK2; GPR1;	GO:0007218~neuropeptide signaling pathway	5	108	4.62962962962963	0.0448607677790116	0.138776528902931	1	1	0.96737636712778	0.99546503601856	1
down	GM2A; ALDH1A3; TNR;	GO:0050885~neuromuscular process controlling balance	3	44	6.81818181818182	0.0462239599187637	0.138776528902931	1	1	0.969574949780343	0.99546503601856	1
down	ALDH3A1; DUOX2; DUOX1;	GO:0051591~response to cAMP	3	44	6.81818181818182	0.0462239599187637	0.138776528902931	1	1	0.969574949780343	0.99546503601856	1
down	UBE2E2; RNF5; STUB1;	GO:0070534~protein K63-linked ubiquitination	3	44	6.81818181818182	0.0462239599187637	0.138776528902931	1	1	0.969574949780343	0.99546503601856	1
down	CHD5; WRNIP1; RUVBL2; ANXA1;	GO:0032508~DNA duplex unwinding	4	75	5.33333333333333	0.0465093081513721	0.138776528902931	1	1	0.969574949780343	0.99546503601856	1
up	PDGFB; FN1; PDGFA; WNT5A; GAS6; SIRT6; PDGFC; SPHK1;	GO:0048146~positive regulation of fibroblast proliferation	8	48	16.6666666666667	0.0479350234283855	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
up	TBX1; LAMB1; LAMC1; NOTCH1; SOX9; SFRP1; HTRA1; NODAL; SMO;	GO:0050679~positive regulation of epithelial cell proliferation	9	57	15.7894736842105	0.0481040835686998	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
down	EGFR; LTF; ALOX15; ECM1;	GO:0001503~ossification	4	76	5.26315789473684	0.0483222935357824	0.138776528902931	1	1	0.969574949780343	0.99546503601856	1
up	SNCA; WNT5A; CD151; TFR2; MAPK8IP1;	GO:0045807~positive regulation of endocytosis	5	23	21.7391304347826	0.0484982818603781	0.642794402849804	1	1	0.999999845920836	0.999999845920836	1
down	CLDN7; ERBB3; ANGPT1;	GO:0007162~negative regulation of cell adhesion	3	45	6.66666666666667	0.0487009471493616	0.138776528902931	1	1	0.972004962185808	0.99546503601856	1
down	GSTP1; TLE1; NLRX1;	GO:0043124~negative regulation of I-kappaB kinase/NF-kappaB signaling	3	45	6.66666666666667	0.0487009471493616	0.138776528902931	1	1	0.972004962185808	0.99546503601856	1
down	PF4; GATA1; EIF6;	GO:0045652~regulation of megakaryocyte differentiation	3	45	6.66666666666667	0.0487009471493616	0.138776528902931	1	1	0.972004962185808	0.99546503601856	1
